Introduction {#s1}
============

Skin is a highly structured organ in which stem cell self-renewal, cell proliferation and differentiation are coordinated to maintain homeostasis. In addition to hair follicles and other skin appendages, the interfollicular epidermis (IFE; non-haired skin) comprises distinct cellular populations. IFE stem cells reside in the basal cell layer; these cells both self-renew and generate the terminally differentiated outer cell layers which function as barriers to the external environment and prevent loss of body fluids ([@bib13]; [@bib23]; [@bib24]; [@bib46]).

Organismal aging, or physical aging, is defined as tissue impairment arising from the accumulation of numerous intrinsic and extrinsic factors that induce cell damage chronologically. The relationship between organismal aging and stem cells is an inescapable bond, and the heterogeneity of stem cells in organs may be reduced with aging ([@bib16]). Human skin aging is exemplified by alterations in the dermis and skin appendages, such as the thinning of dermis, dryness, wrinkles, gray hair and hair loss ([@bib59]). However, the influence of aging on IFE has been controversial. Although decreased epidermal proliferation has been reported in in vitro and in vivo studies using aged individuals and mice ([@bib13]; [@bib14]; [@bib17]), several recent studies have reported contradictory results, showing sustained and increased proliferation in the aged epidermis ([@bib7]; [@bib65]). Thus, how organismal aging affects the IFE and its stem cells has not been clarified ([@bib25]).

The extracellular matrix proteins of the basement membrane zone (BMZ) are important components of the IFE stem cell niche and connect the dermis and epidermis functionally. Type XVII collagen (COL17) is a type II transmembrane protein that is located along the hemidesmosomes in the BMZ. The N-terminus of COL17 is localized in hemidesmosomes, and its extracellular domain reaches the lamina densa ([@bib41]). Non-hemidesmosomal COL17 in keratinocytes and human skin has also been reported ([@bib22]). COL17 has been characterized as a target protein in the autoimmune blistering disease bullous pemphigoid ([@bib52]) and also as being the defective protein in junctional epidermolysis bullosa (JEB), a congenital blistering disease ([@bib12]). Recently, COL17 has been shown to form a niche for hair follicle stem cells (HFSCs), as mice lacking the protein and human JEB patients with mutations in *COL17A1*, the open-reading frame encoding COL17, exhibit a premature aged skin phenotype, including gray hair and hair loss ([@bib40]; [@bib50]; [@bib67]). Additionally, reduced labeling of epidermal basement membrane proteins, including COL17, in human skin has been associated with aging ([@bib31]). However, the role of COL17 in maintaining IFE and its stem cells is still unclear.

In the present study, we explore the comprehensive role of COL17 in regulating IFE homeostasis and also characterize age-related IFE alterations associated with a modified BMZ, including COL17. We show that COL17 is indispensable for regulating IFE proliferation in neonatal mice through activating the Wnt pathway. The IFE hyperproliferation is induced by organismal aging and can be reversed by COL17 replenishment.

Results {#s2}
=======

COL17 deficiency leads to epidermal hyperproliferation in neonatal IFE {#s2-1}
----------------------------------------------------------------------

We investigated the phenotype of paw skin to study IFE in *Col17a1*−/− mice ([@bib50]) in the absence of hair follicles. Neonatal IFE skin (P1, postnatal day 1) of *Col17a1*−/− mice showed transient epidermal hyperproliferation, as demonstrated by counting the epidermal layers and the numbers of epidermal cells and phospho-Histone H3 (PH3)-positive cells ([Figure 1a--b](#fig1){ref-type="fig"}). The numbers of proliferating cell nuclear antigen (PCNA)- and Bromodeoxyuridine (BrdU)-positive cells in the *Col17a1*−/− IFE basal cells at P1 were also increased compared with the controls ([Figure 1c](#fig1){ref-type="fig"}), indicating that COL17 deletion affects both the S and M phases in the cell cycle of IFE neonatal keratinocytes. The proliferative IFE phenotype of *Col17a1*−/− mice gradually waned postnatally, and the epidermal thickness and the number of PH3-positive cells became comparable with those of the controls at P20 ([Figure 1a--b](#fig1){ref-type="fig"}).10.7554/eLife.26635.003Figure 1.COL17 deletion induces transient IFE hyperproliferation in neonates.(**a**) Hematoxylin and eosin (H&E) staining and E-cadherin (E-cad) labeling (with PI nuclear counterstain) of *Col17a1−/−* and control IFE skin samples from *Col17a1+/-* or *Col17a1+/+* littermates (Control) at P1 (n = 5) and P20 (n = 4). Scale bar: 20 μm. Quantitation of the number of epidermal layers and epidermal cell counts. The values are shown as relative ratios to the controls. (**b**) PH3 staining at P1 and P20. Scale bar: 20 μm. The number of epidermal basal cells positively labeled for PH3 per mm epidermis (n = 4). BM, basement membrane. (**c**) PCNA and BrdU labeling at P1. Scale bar: 20 μm. Quantitation of PCNA- (n = 5) and BrdU-positive basal cells (n = 4). The values are shown as relative ratios to the controls. (**d**) Quantitative RT-PCR (qRT-PCR) of *Itga6*, *Itgb1*, *Tgm1*, *Ppl* and *Ivl* mRNAs (n = 5). (**e**) Loricrin and cleaved caspase-3 staining (representative images from 3 mice). Scale bar: 20 μm. BM, basement membrane. (**f**) An in silico model of the epidermal cell proliferation upon the reduced adhesion of committed progenitor cells to the BMZ. The details are described in the Material and Methods. The data in all of the histograms are the means ± SE. \*0.01\<p\<0.05, \*\*0.001\<p\<0.01, \*\*\*\*p\<0.0001. Student's t-tests.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.003](10.7554/eLife.26635.003)10.7554/eLife.26635.004Figure 1---figure supplement 1.Barrier function assay of *Col17a1*−/− and littermate controls (E18.5).Inflammatory cell infiltration in the dermis of *Col17a1*−/− and littermate controls (P1) and ultrastructural findings of the basement membrane zone in the paw epidermis of *Col17a1*−/− and littermate controls (P1). (**a**) mRNA expression levels of *Itgb4*, *Lamb3* and *Lamc3* (n = 4). (**b**) Dye permeabilization with Toluidine blue (representative images from three *Col17a1*−/− mice and eight control mice). (**c**) Transepidermal water loss (TEWL) (n = 3 for *Col17a1*−/− mice; n = 8 for control). (**d**) In the *Col17a1*−/− paw epidermis, hemidesmosomes (HD) comprising inner plaques (IP), outer plaques (OP) and anchoring fibrils were blurred compared with those of the *Col17a1-/*- mice. LL: Lamina Lucida, LD: Lamina densa. Scale bar = 0.2 μm. Representative images from two mice. (**eg**) Quantification of immune cells in the paw skin dermis of *Col17a1−/−* and control mice (n = 4). The data are the means±SE. \*0.01\<p\<0.05, \*\*0.001\<p\<0.01, Student's t-tests.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.004](10.7554/eLife.26635.004)10.7554/eLife.26635.005Figure 1---figure supplement 2.Proliferative ability of the back skin IFE from *Col17a1−/−* mice and NHEKs treated with *COL17A1* siRNAs.(**a**) PH3- and PCNA-positive cells in the *Col17a1*−/− back skin (n = 4 for *Col17a1*−/−; n = 5 for control). (**b**) *COL17A1* knockdown efficiency in NHEKs. The left panel shows COL17 immunoblotting of lysates from NHEKs treated with siRNAs. The right panel shows the qRT-PCR results of *COL17A1* (n = 3). (**c--d**) Cell proliferation curve (**c**) and slope (**d**) of NHEKs treated with siRNAs (n = 3). (**e--f**) Colony formation assay of NHEKs treated with siRNAs. Gross appearance (**e**), total colony number (f-left) and the percentage of colonies that were larger than 0.5 mm (f-right) (n = 3). The data are presented as the means±SE. \*0.01\<p\<0.05, \*\*0.001\<p\<0.01, Student's t-tests.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.005](10.7554/eLife.26635.005)

We investigated whether the expression levels of markers of basal cells and differentiated cells were altered in the hyperproliferative IFE of *Col17a1*−/− mice at P1. The gene expression of *Itga6*, which might compensate for COL17 deficiency, was increased in *Col17a1*−/− IFE skin, whereas the expression of *Itgb1, itgb4, lamb3 and lamc2* was not altered ([Figure 1d](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1a](#fig1s1){ref-type="fig"}). The mRNA expression levels of *Tgm1*, *Ppl* and *Ivl* were somewhat higher in *Col17a1*−/− IFE skin ([Figure 1d](#fig1){ref-type="fig"}), while loricrin-labeled granular cell layers were not expanded in these mice ([Figure 1e](#fig1){ref-type="fig"}). Dye-permeability and transepidermal water loss at day 18.5 of embryogenesis (E18.5) were comparable between the *Col17a1*−/− mice and the controls ([Figure 1---figure supplement 1b--c](#fig1s1){ref-type="fig"}), indicating that IFE keratinocyte differentiation was not greatly altered in *Col17a1*−/− skin. There was no increase in the number of cells positive for cleaved caspase-3, a marker of apoptosis, in the *Col17a1*−/− epidermis compared with the controls ([Figure 1e](#fig1){ref-type="fig"}). The electron microscopy results indicated that the dermo-epidermal junction of the *Col17a1−/−* IFE presented hypoplastic hemidesmosomes in accordance with previous observations on the back skin of *Col17a1−/−* mice ([@bib50]) ([Figure 1---figure supplement 1d](#fig1s1){ref-type="fig"}). There were no significant differences in the number of inflammatory infiltrates, including CD3+, F4/80+ and Ly-6G+ cells, in the dermis of *Col17a1*−/− mice and control mice, which excludes inflammation as a contributor to immature hemidesmosome formation ([Figure 1---figure supplement 1e--g](#fig1s1){ref-type="fig"}).

To explain the transient epidermal hyperproliferation of the *Col17a1*−/− neonatal IFE, we exploited an in silico model ([@bib26]) to recapitulate the epidermal development. As COL17 serves as a linker between the epidermis and dermis and is expressed in basal cells, most of which are committed progenitor cells in the epidermis ([@bib9]; [@bib34]), epidermal thickness was calculated upon the loosening of the attachment of committed progenitor cells to the BMZ. In the model with diminished adhesion, the epidermal thickness was transiently increased and gradually returned to the baseline ([Figure 1f](#fig1){ref-type="fig"}), which was compatible with the experimental observations of *Col17a1*−/− neonates and with the transient hypertrophy of *Itga6-* and *Itgb1*-null epidermis ([@bib5]; [@bib47]). These data suggest that COL17 deletion induces epidermal thickening by the hyperproliferation of IFE keratinocytes, at least partially through the loosening of dermo-epidermal adhesion at the neonatal stage.

The site specificity of the hyperproliferative phenotype in the neonatal paw epidermis of *Col17a1*/-/ mice was confirmed by the comparable expression of proliferation markers in the back skin IFE of *Col17a1−/−* mice and control mice ([Figure 1---figure supplement 2a](#fig1s2){ref-type="fig"}). The discordance between the paw epidermis and back skin IFE might be explained either by the influence of hair follicle development on the back skin IFE or by the distinct regulation of the IFE at each body site ([@bib61]; [@bib62]; [@bib63]). We also investigated cell-intrinsic properties due to COL17 defects using cultured normal human epidermal keratinocytes (NHEKs). The cell proliferation rates of NHEKs treated with *COL17A1* siRNAs were slightly decreased ([Figure 1---figure supplement 2b--d](#fig1s2){ref-type="fig"}), which is compatible with reduced proliferation of cultured keratinocytes derived from *Col17a1−/−* mice ([@bib67]), and the colony-forming abilities of these cells were similar to those of control cells ([Figure 1---figure supplement 2e--f](#fig1s2){ref-type="fig"}). These data indicate that the proliferation potential of *Col17a1*−/− IFE is dependent on in vivo conditions.

COL17 regulates neonatal IFE proliferation through Wnt-β-catenin signaling {#s2-2}
--------------------------------------------------------------------------

Various signaling molecules are involved in controlling hair follicle stem cells and epidermal homeostasis ([@bib27]); the relationships between these signaling molecules and BMZ proteins are only partially understood ([@bib38]; [@bib60]; [@bib67]). To further explore the underlying mechanisms of the transient epidermal hyperproliferation phenotype of *Col17a1*−/− IFE, we first screened the gene expression profiles of the receptors, co-receptors, transcription factors and cofactors of the major signaling pathways, including Wnt, TGF-β/BMP, Notch, Hedgehog and FGF in neonatal *Col17a1*−/− and control skin samples. The screening data showed that the expression levels of Wnt-related molecules (*Fzd4*, *Nfatc2*, *Nfatc4* and *Tcf7*) were significantly decreased in *Col17a1*−/− neonatal IFE skin compared with controls ([Figure 2---figure supplement 1a](#fig2s1){ref-type="fig"}). Although the expression of some TGF-β−related genes was altered in *Col17a1*−/− IFE skin ([Figure 2---figure supplement 1a](#fig2s1){ref-type="fig"}), the TGF-β and p-Smad2 immunostaining in *Col17a1*−/− IFE keratinocytes was comparable with that in IFE cells in the controls, in contrast to the TGF-β and p-Smad2 reduction in *Col17a1*−/− HFSCs ([@bib67]) ([Figure 2---figure supplement 1b--c](#fig2s1){ref-type="fig"}). The gene expression profiles for Notch, Hedgehog and the FGF pathway were not significantly affected upon COL17 deletion ([Figure 2---figure supplement 1a](#fig2s1){ref-type="fig"}).

To validate these findings, we analyzed the gene expression profiles of specific Wnt-related molecules in the independent replication samples. In line with the screening qPCR data, the expression levels of the Wnt target genes (*Tcf7 l1*, *Tcf7 l2*, and *Axin2*), the receptor gene (*Fzd4*), and stimulatory Wnt genes (*Wnt2*, *Wnt2b*, *Wnt5a*) were significantly downregulated in *Col17a1*−/−mice, whereas expression of the inhibitory Wnt gene (*Wnt4*) was increased ([Figure 2a](#fig2){ref-type="fig"}) ([@bib4]; [@bib42]). The changes in these genes were paralleled by a reduction of basal cells positive for LEF1, a nuclear Wnt mediator of Wnt signaling, in neonatal *Col17a1*−/− mice IFE ([Figure 2b](#fig2){ref-type="fig"}). This reduction was also transient, and the number of LEF1-positive basal cells was comparable between the *Col17a1*−/− mice and the control mice at P4, which might account for the transient epidermal hyperproliferation of the paw IFE in *Col17a1*−/− mice. As β-catenin binds to LEF1 in the nucleus in the Wnt-canonical pathway ([@bib32]), we performed β-catenin immunostaining. The number of nuclear β-catenin-positive cells in *Col17a1*−/− mice IFE was diminished compared to the controls ([Figure 2c](#fig2){ref-type="fig"}).10.7554/eLife.26635.006Figure 2.COL17 deficiency destabilizes Wnt-β-catenin signaling in neonates.(**a**) qRT-PCR of Wnt-related molecules in *Col17a1*−/− and control IFE skin samples at P1 (n = 5). Student's t-test. (**b**) LEF1 staining of *Col17a1*−/− and control IFE skin at P1 (n = 5), P4 (n = 4) and P10 (n = 4). Inlet: higher magnification of LEF1-positive basal cells at P1. Scale bar: 20 μm. Quantitation of LEF1-positive basal cells as a percentage of all basal cells (%). Student's t-test. (**c**) β-catenin staining of *Col17a1*−/− and control IFE skin at P1. Nuclear β-catenin accumulation is indicated with arrows. The quantification of nuclear β-catenin-positive cells (n = 3). Student's t-test. Scale bar: 20 μm. (**d**) Wnt activity in STF293 cells expressing hCOL17 treated with Wnt3a CM (n = 3). One-way ANOVA test, followed by Tukey's test. (**e**) Wnt activities in the hindpaw IFE from ins-Topgal+ (Control: left) and ins-Topgal+:*Col17a1−/−* (*Col17a1−/−*: right) mice. Calculated areas devoid of hair follicles or sweat glands are indicated with squares in the representative figures. The results are quantified as the Wnt-activated area per unit (n = 4). Scale bar: 100 μm. Mann-Whitney test. (**f**) H&E, E-cad, PH3 and PCNA staining of IFE skin samples from K14-ΔNLef and littermate controls at P1. Scale bar: 20 μm. The numbers of epidermal layers, epidermal cell counts and PCNA- and PH3-positive basal cells (n = 4). Student's t-test. (**g**) Quantification of BrdU- and PH3-positive cells in WT paw skin IFE treated with Wnt inhibitors (IWP-2 (n = 6) vs DMSO (n = 5) or Wnt-C59 (n = 6) vs DMSO (n = 4)). The data are presented as the means ± SE. Student's t-test. \*0.01\<p\<0.05, \*\*0.001\<p\<0.01, \*\*\*0.0001\<p\<0.001, \*\*\*\*p\<0.0001.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.006](10.7554/eLife.26635.006)10.7554/eLife.26635.007Figure 2---figure supplement 1.mRNA profiles of signaling molecules and TGF-β staining.(**a**) qRT-PCR screening of genes involved in the Wnt, TGF-β/BMP, Notch, Hedgehog, and FGF signaling pathways. mRNA samples from IFE skin of *Col17a1*−/− and littermate controls at P1 were analyzed (n = 5). \*0.01\<p\<0.05, Student's t-tests. (**b**) TGF-β-stained IFE of *Col17a1*−/− and littermate controls at P1 (representative images from three mice). (**c**) p-Smad2 staining of IFE from *Col17a1*−/− and littermate controls at P1 (representative images from three mice). Scale bar: 20 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.007](10.7554/eLife.26635.007)10.7554/eLife.26635.008Figure 2---figure supplement 2.The details of LacZ staining in ins-Topgal+ mice with COL17 deficiency.(**a**) Schematic model of murine hindpaw on LacZ staining. The dark blue area indicates sweat glands-abundant regions and the light blue area represents to regions with hair follicles. Sweat glands and hair follicles are major sources of Wnt activities as marked with LacZ. The white area, without sweat glands or hair follicles, shows the regions used for the quantification. (**b**) Gross appearance of LacZ staining on ins-Topgal+ (Control: left) and ins-Topgal+:*Col17a1−/−* (*Col17a1−/−*: right) mice hind paw. Scale bar: 500 μm. (**c**) LacZ staining on ins-Topgal+ (Control: left) and ins-Topgal+:*Col17a1−/−* (*Col17a1−/−*: right) mice in high magnification for quantification. Scale bar: 100 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.008](10.7554/eLife.26635.008)10.7554/eLife.26635.009Figure 2---figure supplement 3.Wnt signaling and proliferation profile in JEB patients epidermis with COL17 deficiency.LEF1, β-catenin and PH3 labeling of skin specimens from two JEB patients and controls. LEF1-positive cells and nuclear β-catenin accumulation are indicated with arrows. Scale bar: 20 μm. Quantification of LEF1- and PH3-positive basal cells per mm epidermis.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.009](10.7554/eLife.26635.009)

To further evaluate the relationship between Wnt signaling and COL17, we utilized SuperTopFlash 293 (STF293) reporter cells ([@bib69]). Overexpression of human COL17 significantly upregulated Wnt activity in this cell line ([Figure 2d](#fig2){ref-type="fig"}). Additionally, to visualize Wnt signaling in vivo, we crossed ins-Topgal+ mice ([@bib44]) with *Col17a1−/−* mice. The LacZ-positive area that was indicative of active Wnt signaling in the IFE was significantly diminished in the ins-Topgal+:*Col17a1−/−* mice ([Figure 2e](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). These results suggest that COL17 expression stabilizes Wnt signaling.

To examine whether these findings correlate with the phenotype of JEB patients with COL17 deficiency, we also performed immunostainings for LEF1, β-catenin and PH3 in JEB skin. In the JEB epidermis, the numbers of LEF1-positive cells and cells with nuclear β-catenin were decreased, while the number of PH3-positive cells was elevated ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}); these findings were compatible with the data from the *Col17a1*−/− mice, although this result requires further investigation due to the small sample size.

We next investigated whether a defect in Wnt signaling in the IFE could be responsible for the hyperproliferation phenotype and whether that phenotype could be reversed by the introduction of COL17. K14-deltaNLef1 mice express a *Lef1* transgene that lacks a β-catenin-binding site under the control of the keratin 14 (K14) promoter and serve as a model of inactive Wnt signaling in the epidermis ([@bib48]). Neonatal K14-deltaNLef1 mice IFE exhibited epidermal thickening and a larger number of PH3-positive basal cells than the controls ([Figure 2f](#fig2){ref-type="fig"}). The number of PCNA-positive basal cells was also increased, albeit not significantly. To confirm that the abated Wnt activities were related to neonatal IFE proliferation in vivo, we intraperitoneally administered Wnt inhibitors (IWP-2 or Wnt-C59) into wild-type mouse neonates ([@bib29]; [@bib6]). The number of BrdU- and PH3-positive epidermal cells was increased in mice treated with these inhibitors at P1 compared with untreated control mice ([Figure 2g](#fig2){ref-type="fig"}). Transgenic rescue by the expression of human COL17 (hCOL17) under the K14 promoter in *Col17a1*−/− mice ([@bib50]) abrogated IFE hyperproliferation and restored LEF1- and nuclear β-catenin-positive basal cells ([Figure 3a,c--d](#fig3){ref-type="fig"}). The expression levels of Wnt-related genes that were altered in *Col17a1*−/− mice at P1 were restored by transgenic rescue with hCOL17 ([Figure 3b](#fig3){ref-type="fig"}). These data demonstrate that COL17 unambiguously contributes to the maintenance of neonatal IFE proliferation via its effect on Wnt signaling.10.7554/eLife.26635.010Figure 3.Induction of human COL17 abrogates epidermal hyperproliferation and the expression of Wnt-β-catenin signaling molecules in neonatal *Col17a1*−/− IFE.(**a**) H&E, E-cad, PH3 and PCNA staining of IFE skin specimens from *Col17a1*+/+ or *Col17a1*+/- (as hCOL17-; CTL (control)) and hCOL17+; *Col17a1*−/− littermate mice at P1. Quantification of epidermal layers, epidermal cell counts, and PH3- and PCNA-positive cells (n = 4). Scale bar: 20 μm. (**b**) Gene expression of Wnt-related molecules in IFE skin samples from hCOL17-; CTL and hCOL17+; *Col17a1*−/− littermate mice at P1 (n = 4). (**c**) LEF1 staining of IFE skin samples from hCOL17-; CTL and hCOL17+; *Col17a1*−/− littermates at P1 (n = 4). Scale bar: 20 μm. (**d**) β-catenin staining of IFE skin samples from hCOL17-; CTL and hCOL17+; *Col17a1*−/− littermates at P1 (n = 4). Nuclear β-catenin is indicated with arrows. The number of nuclear β-catenin-positive cells. Scale bar: 20 μm. The data are the means ± SE. Student's t-tests.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.010](10.7554/eLife.26635.010)

Distribution of COL17 is altered with physical aging {#s2-3}
----------------------------------------------------

Because *Col17a1*−/− mice (3-month-old) clearly exhibited the premature aging phenotypes of gray hair and hair loss ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) ([@bib50]; [@bib67]), we examined the effects of physical aging on the IFE and the relationship between aging and COL17. We compared wild-type (WT) young mice (6 to 10 weeks old) with aged mice (19 to 27 months old). In the IFE of aged mice, the epidermis was thickened, and the numbers of PH3-, BrdU- and PCNA-positive cells were increased ([Figure 4a](#fig4){ref-type="fig"}). This phenomenon was specific to paw skin and was not observed in the back skin IFE ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), as was the case for the neonatal *Col17a1*−/− IFE. These data indicate that physical aging leads to paw IFE hyperproliferation.10.7554/eLife.26635.011Figure 4.Physical aging affects epidermal proliferation and COL17 distribution.(**a**) H&E, E-cad, PH3, BrdU and PCNA staining of IFE skin from young (6--10 weeks old) and aged (19--27 months old) adult C57BL/6 wild-type (WT) mice. Scale bar: 20 μm. The numbers of epidermal layers, epidermal cell counts, and PH3-, BrdU- and PCNA-positive basal cells (n = 5). Student's t-test. (**b**) The gene expression levels of *Itga6*, *Itgb1*, *Tgm1*, *Ppl, Evpl,* and *Col17a1* in IFE skin samples from young and aged WT mice (n = 5 for *Itga6*, *Itgb1*, *Tgm1* and *Col17a1*; n = 3 for *Ppl* and *Evpl*). Student's t-test. (**c**) COL17 staining (antibodies to the juxtamembranous portion) in IFE skin samples from the following groups: young and aged WT mice (n = 5), young (\<15 years old) and aged (\>85 years old) normal human individuals (representative images from three human samples), and *Klotho*+/- and *Klotho*−/− littermates at 6 weeks (representative images from three mice). Scale bar: 20 μm. The quantitative fluorescent intensity of lateral membrane of IFE basal cells from young and aged WT mice (n = 5). Mann-Whitney test. (**d**) COL17 labeling following the Triton X-100 treatment of IFE skin from young/aged WT mice and human individuals (representative images from three samples). Scale bar: 20 μm. (**e**) The optical sectioning of 3D reconstructed whole mount COL17-stained skin from young and aged murine WT IFE. The IFE cell membrane was visualized with wheat germ agglutinin (WGA). DAPI (4\',6-diamidino-2-phenylindole) was used for nuclear staining. Scale bar: 10 μm. The quantitative fluorescent intensity of COL17 in lateral membrane of IFE basal cells from young and aged WT mice (n = 6). Mann-Whitney test. (**f**) The distributions of COL17 and desmogleins 1 and 2 in young murine WT IFE using N-SIM (structured illumination microscopy) image reconstruction (representative images from two mice). Basal keratinocytes were depicted by white lines. Scale bar: 5 μm. BM, basement membrane. The data are the means ± SE. \*0.01\<p\<0.05, \*\*0.001\<p\<0.01, \*\*\*0.0001\<p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.011](10.7554/eLife.26635.011)10.7554/eLife.26635.012Figure 4---figure supplement 1.Gross appearance of *Col17a1−/−* and littermate controls (3 months old).(**a**) Gray and sparse hair was noted in *Col17a1*−/− skin. (**b**) Scaly paw skin was observed in *Col17a1*−/− skin (representative images from four mice).**DOI:** [http://dx.doi.org/10.7554/eLife.26635.012](10.7554/eLife.26635.012)10.7554/eLife.26635.013Figure 4---figure supplement 2.Proliferation markers in back skin from young and aged mice.Quantification of PH3- and PCNA- positive cells in young and aged paw skin (n = 5). Student's t-test.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.013](10.7554/eLife.26635.013)10.7554/eLife.26635.014Figure 4---figure supplement 3.Intracellular COL17 labeling of the IFE from young/aged WT mice and human individuals.Antibodies against the intracellular portions of COL17, which recognize the full-length protein, were used. The antibodies do not react with the shed ectodomain of COL17. Scale bar: 20 μm. Samples from *Klotho*+/− and *Klotho*−/− littermates were obtained at the age of 6 weeks. Representative images from three samples.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.014](10.7554/eLife.26635.014)10.7554/eLife.26635.015Figure 4---figure supplement 4.Expression of BMZ and extracellular matrix proteins in the IFE skin of young and aged WT mice and healthy individuals.(**a**) Staining of integrin α6 and β1 in young/aged mouse and human IFE samples (representative images from five mice). Scale bar: 20 μm. (**b**) Labeling of BP230 and plectin in the mice IFE (representative images from five mice). Scale bar: 20 μm. (**c, d**) Expression data from the microarray (four mice from young and aged groups, respectively) of genes encoding collagens (**c**) and laminins (**d**). The fold changes are based on the young group.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.015](10.7554/eLife.26635.015)10.7554/eLife.26635.016Figure 4---figure supplement 5.Analysis of epidermal proteases in IFE skin samples from young and aged WT mice.(**a**) Expression levels from the microarray analysis of genes encoding proteases involved in COL17 digestion and degradation (n = 4). (**b**) COL17 staining in *Serpine1*−/− and littermate control mice IFE at 8 weeks (representative images from four mice). The antibody against the juxtamembranous NC16A domain of COL17 was used. (**c**) ELANE labeling of young and aged IFE (representative images from five mice). Scale bar: 20 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.016](10.7554/eLife.26635.016)

The gene expression levels of *Itga6* and *Itgb1* were decreased in the aged mouse IFE, whereas that of *Col17a1* did not change ([Figure 4b](#fig4){ref-type="fig"}). Furthermore, the expression levels of differentiation markers (*Tgm1*, *Ppl*, and *Evpl*) were not greatly affected. Although *Col17a1* gene expression was unaffected, the distribution of COL17 was dramatically altered in the IFE of aged mice and humans. The apico-lateral portion of COL17 (non-hemidesmosomal COL17) was greatly reduced in the IFE of aged mice and humans, as detected with antibodies targeting the extracellular portion of COL17 ([Figure 4c](#fig4){ref-type="fig"}) and is in line with the recent publication on age-related alterations of COL17 in human skin ([@bib31]). This phenomenon was also observed in the IFE of *Klotho*−/− mice, a premature aging model ([@bib30]). The involvement of COL17 proteolytic cleavage, so-called ectodomain shedding ([@bib51], [@bib53]), in the altered COL17 distribution was excluded using several antibodies that recognize the intracellular portions of COL17 ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}).

To confirm the depletion of non-hemidesmosomal COL17 in the aged IFE, the sections were treated with Triton X-100 prior to immunostaining ([@bib22]). In both mouse and human skin, Triton X-100-treated young IFE lost the apico-lateral portion of COL17 and resembled the aged epidermis ([Figure 4d](#fig4){ref-type="fig"}). To further examine the reduction in the apico-lateral portion of COL17 in aged mice, we performed whole-mount staining of the IFE ([Figure 4e](#fig4){ref-type="fig"}). In 3D-reconstructed images, COL17 was confined to the basement membrane in the aged IFE, while basal cells of young mice had COL17 that was associated with the apical, lateral and basal membranes. Using high-resolution structured illumination microscopy (SIM) imaging on young WT mouse IFE ([Figure 4f](#fig4){ref-type="fig"}), COL17 was detected at the apico-lateral cell periphery of basal keratinocytes but did not co-localize with desmosomal proteins (desmogleins 1 and 2), indicating that the apico-lateral COL17 in basal keratinocytes was not incorporated into desmosomes, which are highly insoluble. In contrast to COL17 dynamics with aging, the distributions of integrins α6 and β1 were not modified by aging ([Figure 4---figure supplement 4a](#fig4s4){ref-type="fig"}). Other hemidesmosomal proteins (BP230 and Plectin) were also unchanged ([Figure 4---figure supplement 4b](#fig4s4){ref-type="fig"}). Sustained *Col17a1* gene expression in IFE skin contrasted with the decreased expression of many collagens and laminins with aging ([Figure 4---figure supplement 4c--d](#fig4s4){ref-type="fig"}). These results suggest that physical aging leads to paw IFE hypertrophy and modifies COL17 distribution in the epidermis in a posttranslational manner.

Atypical PKC controls the distribution of COL17 in IFE {#s2-4}
------------------------------------------------------

To elucidate the mechanisms that underlie the altered COL17 distribution that occurs with physical aging, we reproduced the environment of aged IFE. Because calcium distribution is changed in the aged epidermis ([@bib8]) and the calcium concentration in the epidermis is lower in aged individuals than in young individuals ([@bib58]), whole IFE skin samples collected from young mice were treated with EDTA to simulate changes in calcium concentration in aged IFE. Whole mount staining showed that EDTA treatment eliminated apico-lateral COL17 in basal cells, while hemidesmosomal COL17 was present ([Figure 5a](#fig5){ref-type="fig"}). This finding suggests that the calcium concentration (or the concentrations of other molecules chelated by EDTA) may affect the COL17 distribution in the IFE.10.7554/eLife.26635.017Figure 5.COL17 distribution is modulated by aPKC.(**a**) COL17 staining of whole IFE skin treated with 5 mM EDTA. The quantitative fluorescent intensity of COL17 in basal cells of IFE from control (PBS) and 5 mM EDTA treated (n = 4). Mann-Whitney test. Samples were taken from young adult WT mice at 6--10 weeks. Scale bar: 20 μm. (**b**) Phospho-aPKC labeling (indicated with arrows) and quantitative fluorescent intensity results from young and aged WT IFE skin (n = 4). Mann-Whitney test. Scale bar: 20 μm.(**c**) Representative figures of asymmetric cell division (ACD; scored as perpendicular to basement membrane) and symmetric cell division (SCD; in parallel to basement membrane) in young IFE. Survivin staining indicates the direction of the cell division. Laminin β1 signifies basement membrane. Scale bar: 10 μm. Graph of percentage of ACD and SCD in young and aged IFE (n = 4). Student's t-test. (**d--e**) The pharmacological inhibition of pan-aPKC (d, 1 μM of Go6983; 0.00002% DMSO as control) and aPKCλ/ζ (e, 10 μM of myr PSI; water as control) in whole IFE skin from young adult WT mice, followed by COL17 staining. The quantitative fluorescent intensity of COL17 in lateral membrane of basal cells from control and 1 μM Go6983 treated (**d**) and 1 μM myr PSI (**e**) (n = 4). Mann-Whitney test. Scale bar: 10 μm. BM, basement membrane. (**f--h**) EDTA treatment (5 mM; PBS as control, **f**) and pharmacological inhibition of pan-aPKC (g, 1 μM of Go6983; 0.00002% DMSO as control) and aPKCλ/ζ (h, 10 μM of myr PSI; water as control) on 3D epidermis. The relative fluorescent intensity of COL17 in lateral membrane of basal cells was measured (n = 4). Mann-Whitney test. BM, basement membrane. Scale bar: 20 μm. The data are the means ± SE. \*0.01\<p\<0.05, \*\*0.001\<p\<0.01, \*\*\*0.0001\<p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.017](10.7554/eLife.26635.017)

Among the numerous cellular events influenced by calcium dynamics, we focused on atypical protein kinase C (aPKC), a key regulator of epithelial polarity ([@bib49]). The expression levels of aPKCζ and aPKCλ/ι, aPKC isoforms expressed by basal epidermal cells are dependent on the calcium concentration in cultured keratinocytes ([@bib21]), and the ablation of aPKCλ/ι in the epidermis leads to premature aging phenotypes, such as gray hair, hair loss and IFE thickening, closely resembling *Col17a1*−/− mice ([@bib49]; [@bib55]). Phospho-aPKC, an active form of aPKC, was reduced in IFE with aging ([Figure 5b](#fig5){ref-type="fig"}). Consistent with this finding, the axis of cell division in the aged IFE tended toward asymmetric cell division (ACD) ([Figure 5c](#fig5){ref-type="fig"}). This phenotype emulates the adult IFE of aPKCλ conditional-null mice ([@bib49]). To recapitulate aged skin with attenuated aPKC, we treated young mouse IFE samples with Go6983, a pan-PKC inhibitor, and myristoylated pseudosubstrate inhibitor (myr PSI), which is specific for aPKCζ and aPKCλ/ι ([@bib18]; [@bib21]; [@bib64]). According to the whole mount staining, the pharmacological inhibition of aPKC diminished the apico-lateral COL17 in basal cells ([Figure 5d--e](#fig5){ref-type="fig"}). EDTA treatment and aPKC inhibition also diminished apico-lateral membranous COL17 in basal cells of reconstructed human 3D epidermis ([Figure 5f--h](#fig5){ref-type="fig"}). These data indicate that an aging-induced alteration of aPKC contributes to spatial changes in COL17 in the IFE.

COL17 undergoes posttranslational modifications, such as ectodomain shedding and degradation, in physiological and pathological settings through the action of several proteases, such as disintegrin and metalloproteinases 9, 10, and 17 (ADAM9/10/17), matrix metalloproteinase-9 (MMP9), neutrophil elastase (ELANE) and other serine proteases ([@bib22]; [@bib52]). There were no discernible changes between aged and young IFE skin in the expression levels of the proteases genes known to degrade COL17 ([Figure 4---figure supplement 4a](#fig4s4){ref-type="fig"}). The involvement of MMP9 in COL17 degradation in aged IFE was further excluded by the observation of the IFE in *Serpine1*−/− mice, which lack plasminogen activator inhibitor-1, blocking MMP9 activity ([Figure 4---figure supplement 4b](#fig4s4){ref-type="fig"}). ELANE, which degrades COL17 adjacent to HFSCs ([@bib40]), was located along the BMZ of the IFE, an expression pattern different from that is seen in hair follicles and back skin ([Figure 4---figure supplement 4c](#fig4s4){ref-type="fig"}). Physical aging did not affect ELANE labeling in the IFE. These data suggest that proteases may not play major roles in the loss of apico-lateral COL17 in the IFE.

Overexpression of human COL17 ameliorates hyperproliferative state in the aged epidermis {#s2-5}
----------------------------------------------------------------------------------------

Next, we tested whether hCOL17 overexpression could reverse the aged IFE phenotype. K14-hCOL17 transgenic mice, which overexpress hCOL17 under the K14 promoter, showed COL17 on all surfaces of IFE basal cells at an age \>19 months ([Figure 6a](#fig6){ref-type="fig"}). In association with this observation, the epidermis was thinner, and the numbers of PH3- and PCNA-positive cells were reduced in the K14-hCOL17 aged IFE compared to the wild type ([Figure 6b](#fig6){ref-type="fig"}). However, the expression levels of *Itga6* and *Itgb1* were similar in K14-hCOL17 aged IFE and age-matched controls ([Figure 6c](#fig6){ref-type="fig"}). These data suggest that COL17 might act downstream of these stem cell markers and can keep the IFE in a juvenile state when overexpressed. Premature aged *Col17a1*−/− IFE (3 months old, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) exhibited epidermal thickening with an increased number of BrdU-positive basal cells, while the numbers of PCNA- or PH3-positive cells were comparable with age-matched controls ([Figure 6d](#fig6){ref-type="fig"}). This result was akin to wild-type aged IFE with a loss of apico-lateral COL17 ([Figure 4c](#fig4){ref-type="fig"}). Unlike neonatal IFE hypertrophy via inactive Wnt signaling, there were no obvious alterations in Wnt-related molecules in the young adolescent IFE ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). These results demonstrate that COL17 overexpression suppresses epidermal hyperproliferation associated with physical aging in the IFE.10.7554/eLife.26635.018Figure 6.Overexpression of human COL17 ablates hyperproliferation in aged IFE.(**a**) COL17 labeling and its quantitative fluorescent intensity in IFE skin from WT and K14-hCOL17 aged mice (\>19 months old) (n = 5). The antibody used in this assay detects both human and murine COL17. Scale bar: 20 μm. Mann-Whitney test. (**b**) H&E-, E-cad-, PH3- and PCNA-stained skin samples from WT and K14-hCOL17 aged IFE. The numbers of epidermal layers, total epidermal cell counts, and PH3- and PCNA-positive basal cell counts (n = 5 for H&E, E-cad, and PCNA staining; n = 4 for PH3 in aged K14-hCOL17 mice; n = 3 for PH3 of aged WT mice). Student's t-test. Scale bar: 20 μm. (**c**) The gene expression levels of *Itga6* and *Itgb1* in IFE skin samples from WT and K14-hCOL17 aged IFE (n = 5). Student's t-test. (**d**) H&E-, E-cad-, PH3- and PCNA-staining; quantifications of epidermal layers; total epidermal cells; and PH3-, PCNA-, and BrdU-positive basal cells in the IFE of *Col17a1*−/− mice and littermate controls (3 months old) (n = 4). Student's t-test. Scale bar: 20 μm. The data are the means ± SE. \*0.01\<p\<0.05, \*\*0.001\<p\<0.01.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.018](10.7554/eLife.26635.018)10.7554/eLife.26635.019Figure 6---figure supplement 1.qRT-PCR assessment of Wnt-related molecules in IFE skin samples from *Col17a1*−/− and littermates at the age of 12 weeks.The data are the means±SE of three mice per each group. Student's t-tests.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.019](10.7554/eLife.26635.019)

Discussion {#s3}
==========

BMZ proteins, including COL17, are key attachment structures that support epidermal cell homeostasis throughout life ([@bib72]). Previously, it has been suggested that COL17 serves as a niche for HFSCs ([@bib40]), which subsequently maintain melanocyte stem cells ([@bib67]). Here, we present the unidentified role of COL17 in regulating homeostasis in the paw IFE in terms of proliferation ([Figure 7](#fig7){ref-type="fig"}). COL17 deletion in the neonatal epidermis led to the transient hyperproliferation of the IFE, mediated via waned Wnt-β-catenin signaling. Physical aging led to increased IFE proliferation and the loss of the non-hemidesmosomal COL17 distribution associated with altered aPKC signaling. The restoration of COL17 in aged IFE reversed the hyperproliferative state.10.7554/eLife.26635.020Figure 7.A model of the role of COL17 in maintaining IFE homeostasis.A graphical abstract of this study. COL17 regulates paw IFE homeostasis in coordination with Wnt signaling at the neonatal stage. Physical aging diminishes non-hemidesmosomal COL17 labeling in IFE keratinocytes, leading to IFE hyperproliferation, associated with altered aPKC activities.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.020](10.7554/eLife.26635.020)

Wnt-β-catenin signaling is one of master regulators of skin development and homeostasis in several components, including hair follicles, other appendages and the IFE ([@bib33]; [@bib37]). Activating and inactivating mutations of Wnt-β-catenin signaling molecules give rise to distinct phenotypes in the IFE of murine back skin in terms of proliferation and differentiation ([@bib33]). Recently, the relationship between the IFE of murine paw skin and Wnt-β-catenin signaling was described ([@bib34]). IFE basal cells require Wnt-β-catenin signaling to proliferate and express both Wnt ligands and inhibitors by an autocrine process in adolescent mice ([@bib34]). Our study uncovers the role of COL17-stabilized Wnt signaling in governing neonatal IFE proliferation, although the interaction between COL17 and Wnt-related molecules remains elusive. Our observation of IFE hyperproliferation in the neonatal paw under inactive Wnt signaling (either by genetically modified mice or by inhibitors) is in contrast to the observed IFE hypotrophy in 1-month-old mice with inducible β-catenin loss-of-function ([@bib34]). This discrepancy might be due to the difference of the observational time points (neonate vs 1-month-old) and/or of the model systems used in each study (conventional vs inducible).

Integrins, which are also BMZ components, have been implicated as having functional roles in regulating epidermal proliferation and differentiation ([@bib38]; [@bib73]). Interestingly, mice and human epidermis deficient in Kindlin-1, an integrin co-activator, also show altered Wnt and TGF-β signaling ([@bib60]). In contrast to *Col17a1*−/− IFE, the absence of Kindlin-1 resulted in the activation of Wnt signaling in the IFE. The previous and current findings suggest that the regulation of Wnt signaling in the IFE is subject to complex regulation by the epidermal BMZ.

For epidermal maintenance and proliferation, the presence of epidermal stem cells is essential. However, the theories on how these stem cells reside in the epidermis and how they regulate epidermal homeostasis remain controversial and may be dependent on the location on the body ([@bib39]; [@bib61]; [@bib63]; [@bib66]). In the IFE, it is proposed that the majority of basal cells exist as plausible committed progenitors (CPs), which undergo cell division and differentiation, in part through asymmetric cell divisions ([@bib1]; [@bib9]). In the foot pad, the proliferative potentials of CPs are elevated compared to other epidermal sites, and the clones of foot pad CPs are also enlarged in aged skin ([@bib11], [@bib10]; [@bib65]). Other in vitro studies report the expansion of proliferative CPs in the aged epidermis ([@bib7]). Our data on hypertrophic IFE in aged skin reinforce the notion that physical aging abolishes the quiescent state of the IFE. This hypothesis requires clarification using conventional fluorescent lineage tracking and/or genetics-based cell fate mapping (e.g. sequencing lineage barcodes) ([@bib74]). Moreover, in our study, the introduction of hCOL17 into aged IFE ablates epidermal hyperproliferation, which is in line with the rejuvenation of HFSCs upon hCOL17 overexpression ([@bib40]). These findings highlight the role of COL17 as an anti-aging molecule in the skin.

As the epidermis is a highly structured tissue, epithelial polarity is required for homeostasis ([@bib68]). Although physiological aging is reported to affect aPKCs in neurons ([@bib56]), the alteration of aPKC in the epidermis upon aging is poorly understood. Our study adds skin to the list of organs in which aPKC is modified with aging. It is noteworthy that in early adult aPKCλ-deficient mice, the IFE showed a similar proliferative phenotype to those of aged WT IFE ([@bib49]; [@bib55]). Asymmetric cell divisions, rather than symmetric cell division, are increased in these mice and are thought to force the gradual loss of quiescence, contributing to premature aged phenotypes ([@bib68]). Altered COL17 distribution with aging or with pharmacological inhibition of aPKC might result from improper cell polarity. To further confirm our results, the observation of COL17 in an aPKCλ-deficient epidermis would be critical as we cannot completely exclude the involvement of non-specific drug effects on the epidermis in COL17 dynamics.

Recently, aging has been illuminated as a trigger for the clonal expansion of stem cells, which disturbs tissue health by means of oncogenesis ([@bib16]). The accumulation of Ki-67-positive cells and prolonged hyperplasia in the aged epidermis during recovery from carcinogenic treatments has been reported ([@bib15]). It would be intriguing to observe skin carcinogenesis upon COL17 deficiency, as its relevance in colon and lung cancers has been described ([@bib35], [@bib36]; [@bib43]).

To further elucidate the mechanisms and dynamics of COL17 in regulating IFE homeostasis, an investigation with either drug-inducible expression or loss of COL17 expression under specific promoters is warranted. The discrepancy in the epidermal growth rate with aging between hyperproliferation, as observed in our findings and the reports of others ([@bib7]; [@bib65]), and hypoproliferation ([@bib13]) might be attributed to the following: (1) UV exposure, which inhibits cell growth, on human skin; (2) a wide divergence of epidermal thickness among the different locations on the body ([@bib57]) and among individual people ([@bib71]); (3) differences in hygiene status among the animal facilities and (4) the influence of the development and cyclical growth of hair on the IFE of haired skin. Our observations can exclude the involvement of most of these extrinsic and intrinsic confounding factors by restricting the monitoring to the paw IFE of congenic mice at a single animal facility. However, it is noteworthy that chronic stimulation via ambulation might affect paw IFE homeostasis with physical aging, which is a limitation of our study. Considering chronic stimulation and lack of UV exposure, it would be fair to say that our data on the murine paw IFE could be extrapolated into the human palmoplantar and buttock epidermis.

In closing, our study has revealed an unrecognized link between COL17 and epidermal proliferation in neonatal and aged IFE. We propose that COL17 is a good candidate to target to prevent epidermal aging and oncogenesis.

Material and methods {#s4}
====================

Animals {#s4-1}
-------

*Col17a1*−/− (RRID:[MGI:3711939](https://scicrunch.org/resolver/MGI:3711939)), K14-hCOL17 (a courtesy gift of Prof. Kim B Yancey), hCOL17+;*Col17a1*−/− (RRID:[MGI:3711948](https://scicrunch.org/resolver/MGI:3711948)), and K14-deltaNLef1 (RRID:[MGI:2667413](https://scicrunch.org/resolver/MGI:2667413)) mice were generated as previously described ([@bib48]; [@bib50]). ins-TOPGAL+ mice (RRID:[IMSR_RBRC05918](https://scicrunch.org/resolver/IMSR_RBRC05918)) ([@bib44]) were obtained from the RIKEN BRC (Tsukuba, Ibaraki, Japan) and bred with *Col17a1*−/− mice to produce ins-Topgal+;*Col17a1*−/− mice. C57BL/6 strain mice and *Klotho*−/− (RRID:[MGI:2181617](https://scicrunch.org/resolver/MGI:2181617)) mice were purchased from Clea (Tokyo, Japan). *Serpine1*−/− mice (RRID:[IMSR_JAX:002507](https://scicrunch.org/resolver/IMSR_JAX:002507)) were purchased from The Jackson Laboratory (Bar Harbor, Maine, USA).

BrdU labeling for proliferation analysis {#s4-2}
----------------------------------------

For label analysis, 1-day-old mice were intraperitoneally administered 10 μg BrdU (BD Pharmingen, New Jersey, USA) per head, and adult mice were intraperitoneally administered 8.33 μg/g per head 4 hr before sacrifice.

Antibodies {#s4-3}
----------

The following antibodies were used: anti-E-cadherin (Cell Signaling Technology, Danvers, Massachusetts, USA; 24E10, RRID: [AB_10694492](https://scicrunch.org/resolver/AB_10694492)), anti-phospho histone H3 (Ser10) (Merck Millipore, Billerica, Massachusetts, USA, RRID: [AB_11210699](https://scicrunch.org/resolver/AB_11210699)), anti-PCNA (Dako, Santa Clara, California, USA; PC10, RRID: [AB_2160651](https://scicrunch.org/resolver/AB_2160651)), anti-BrdU (Dako; M0744, RRID:[AB_10013660](https://scicrunch.org/resolver/AB_10013660)), anti-loricrin (Covance, Princeton, New Jersey, USA, RRID:[AB_10064155](https://scicrunch.org/resolver/AB_10064155)), anti-cleaved caspase-3 (Cell Signaling Technology, RRID:[AB_2341188](https://scicrunch.org/resolver/AB_2341188)), FITC-conjugated anti-CD3e (BioLegend, San Diego, California; 145--2 C11, RRID:[AB_394595](https://scicrunch.org/resolver/AB_394595)), Alexa Fluor 488-conjugated anti-F4/80 (Affymetrix, Santa Clara, California, USA; BM8, RRID: [AB_893479](https://scicrunch.org/resolver/AB_893479)), FITC (fluorescein isothiocyanate)-conjugated anti-Ly-6G (Beckman coulter, Brea, California, USA; RB6-8C5,RRID: [AB_394643](https://scicrunch.org/resolver/AB_394643)), anti-TGFβ1 (Santa Cruz Biotechnology, Dallas, Texas, USA, RRID: [AB_632486](https://scicrunch.org/resolver/AB_632486)), anti-p-Smad2 (Cell Signaling Technology; 138D4, RRID:[AB_490941](https://scicrunch.org/resolver/AB_490941)), anti-LEF1 (Cell Signaling Technology; C12A5, RRID: [AB_823558](https://scicrunch.org/resolver/AB_823558)), anti-β-catenin (BD; 14/Beta-catenin, RRID: [AB_397554](https://scicrunch.org/resolver/AB_397554)), anti-hCOL17 NC16A domain (TS39-3, homemade) ([@bib70]), anti-extracellular portion of hCOL17 (mAb233, homemade) ([@bib54]), anti-murine COL17 NC14A domain (MoNC14A, homemade) ([@bib53]), anti-cytoplasmic portion of COL17 (Abcam, Cambridge, UK; ab186415, 1A8c, homemade [@bib54])), anti-plectin (Abcam; ab32528, RRID: [AB_777339](https://scicrunch.org/resolver/AB_777339)), anti-BP230 (Cosmo bio, Tokyo, Japan; 239, RRID:[AB_1961833](https://scicrunch.org/resolver/AB_1961833)), anti-desmogleins 1 and 2 (PROGEN, Wieblingen, Heidelberg, Germany; DG3.10, RRID: [AB_1284107](https://scicrunch.org/resolver/AB_1284107)), anti-integrin β1 (Chemicon International, Billerica, Massachusetts, USA; MB1.2, RRID: [AB_2128202](https://scicrunch.org/resolver/AB_2128202)), anti-integrin α6 (BD Pharmingen; GoH3, RRID: [AB_2296273](https://scicrunch.org/resolver/AB_2296273)), anti-ELANE (Abcam), anti-phospho aPKC (Santa Cruz; sc-271962, RRID:[AB_10708397](https://scicrunch.org/resolver/AB_10708397)), and anti-survivin (Cell Signaling Technology; 71G4B7, RRID:[AB_10691694](https://scicrunch.org/resolver/AB_10691694)), anti-laminin β1 (Abcam; LT3, RRID: [AB_775971](https://scicrunch.org/resolver/AB_775971)).

Histology {#s4-4}
---------

Specimens from mice paw skin and human skin were fixed in formalin and embedded in paraffin after dehydration or were frozen on dry ice in an optimal cutting temperature (OCT) compound. Frozen sections were fixed with 4% paraformaldehyde (PFA) or acetone or were stained without fixation. Antigen-retrieval with pH 6.0 (citrate) or pH 9.0 (EDTA) buffer was performed on deparaffinized sections. Sections were incubated with the primary antibodies overnight at 4°C. After washing in phosphate-buffered saline (PBS), the sections were incubated with secondary antibodies conjugated with Alexa488, Alexa647 or FITC for 1 hr at room temperature (RT). The nucleus was stained with propidium iodide (PI) or 4\',6-diamidino-2-phenylindole (DAPI). All the stained immunofluorescent samples were observed using a confocal laser scanning microscope (Olympus Fluoview FV1000; Olympus, Tokyo, Japan, RRID:[SCR_014215](https://scicrunch.org/resolver/SCR_014215)). To quantify the relative intensity of the staining, the signals for immunofluorescence were obtained and analyzed using FV1000 software (RRID:[SCR_014215](https://scicrunch.org/resolver/SCR_014215)) or Image J (NIH, Bethesda, Maryland, USA, RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070)). The values were normalized by the section length or by the tissue area and are indicated as arbitrary units (A. U.).

For immunohistochemistry, horseradish peroxidase (HRP)-tagged antibodies were used. Sections were blocked before antibody labeling and counterstained with hematoxylin. Images were captured with a bright field microscope (Nikon, Tokyo, Japan; Keyence, Tokyo, Japan).

For staining, skin samples of normal humans, both young (\<10 years old) and aged (\>85 years old), were obtained from non-sun-exposed areas. To distinguish hemidesmosomal from non-hemidesmosomal COL17 in basal keratinocytes, frozen skin sections were treated with 0.5% Triton X-100 in PBS for 1 hr at RT before primary antibody incubation, as described previously ([@bib22]).

To evaluate the skin thickness, at least three footpad areas per each mouse were counted and averaged. Epidermal cells were quantified as the number of PI-positive cells per epidermal length. The number of epidermal cell layers was evaluated using E-cadherin labeling. The numbers of basal cells positive for proliferation markers and Wnt-related molecules were counted and normalized using the total epidermal length or total basal cell number. For general histological analysis, each immunostaining was repeated in at least three independent experiments, and sweat gland areas were excluded from observation.

For high-resolution structured illumination microscopy (SIM) imaging, an N-SIM microscope (Nikon) with an electron-multiplying charged-coupled device camera (DU-897; Andor Technology, Tokyo, Japan) was used as described previously ([@bib20]). Image reconstruction was performed using NIS-Elements software (RRID:[SCR_014329](https://scicrunch.org/resolver/SCR_014329)).

In division axis orientation determination, the direction of cell division was verified using survivin staining as described previously ([@bib49]). The angle of division was confirmed by scaling the angle of the plane transecting two daughter cells relative to the plane of the basement membrane as labeled laminin β1. The total number of cell divisions including ACD and symmetrical cell division (SCD) were set to 100% per sample.

TOPFLASH assay {#s4-5}
--------------

HEK293 Cells (RRID:[CVCL_0045](https://scicrunch.org/resolver/CVCL_0045), authenticated by STR gene profiling) which constitutively expresses the SuperTopFlash construct (SuperTopFlash 293 (STF293)) ([@bib69]) was cultured in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% bovine serum (Sigma-Aldrich, St. Louis, Missouri, USA) and 1% penicillin-streptomycin-amphotericin B (Wako, Osaka, Japan). The cells used in this assay were subject to regular mycoplasma testing. Wnt 3a-conditioned medium (Wnt3a CM) was kindly provided by S. Takada. Full-length human *COL17A1* cDNA (NM_0004940) was subcloned into the mammalian expression vector pcDNA3.1/Zeo (ThermoFisher, Waltham, Massachusetts, USA) and transfected into STF293 cells. The transfected cells were selected with Zeocin (Thermo Fischer Scientific, Waltham, Massachusetts, USA). STF293 cells stably expressing either human *COL17A1* or empty vector were seeded onto 96-well plates and co-transfected with the pGL 4.75 plasmid, which contains a Renilla reniformis luciferase gene (Promega, Fitchburg, Wisconsin, USA), using Lipofectamine2000 (Invitrogen, Waltham, Massachusetts, USA) and Opti-MEM (Thermo Fischer Scientific). At 24 hr after seeding, Wnt3a CM was added to the medium at at a final concentration of 30% of the total medium by volume. After 2 days of stimulation with the Wnt3a CM, the Firefly and Renilla luciferase activities were measured using a Dual-Luciferase reporter assay system (Promega) and a Spectra Max Paradigm (Molecular device, Tokyo, Japan). All the values were normalized to Renilla luciferase activity.

Wnt inhibitor treatment on WT neonate mice {#s4-6}
------------------------------------------

Either IWP-2 (Sigma Aldrich) or Wnt-C59 (Cayman Chemical, Ann Arbor, Michigan, USA; both dissolved in DMSO) were intraperitoneally injected into WT mice at P0 (IWP-2: 10 mg/g body, Wnt-C59: 20 mg/g body) ([@bib6]; [@bib29]). The paw skin samples were collected 24 hr after injection.

Whole mount staining {#s4-7}
--------------------

For X-gal staining on ins-Topgal+ mice skin, a beta-galactosidase staining kit (Takara-bio, Shiga, Japan) was used according to the provider's protocol. Briefly, hindpaw samples were fixed with 4%PFA for 2 hr at RT and soaked in staining solution overnight. Tissues were mounted with a Mowiol solution. Images for evaluation were collected from the heel of the hind paw to exclude the involvement of hair follicles and sweat glands. The individual light settings of each experiment were identical for both control and *Col17a1−/−* mice, when capturing images with a bright field microscopy (Nikon). The LacZ-positive area was quantified by ImageJ.

For epidermal whole mount staining, epidermal sheets were taken from whole paw mice skin as described previously with some modifications ([@bib28]). For cell membrane detection, Alexa633-conjugated wheat germ agglutinin (Invitrogen, Waltham, Massachusetts, USA) was used. Three-dimensional (3D) reconstruction images were generated, and analyses were performed using the Metamorph software (Molecular Devices, Tokyo, Japan, RRID:[SCR_002368](https://scicrunch.org/resolver/SCR_002368)).

Ex vivo inhibitor treatment {#s4-8}
---------------------------

Whole mice paw skin samples were treated with the following inhibitors for 1 hr at 4°C: EDTA, pan-PKC inhibitor Go6983 (Tocris Bio, Bristol, UK) and myristoylated pseudosubstrate Inhibitor (myr PSI; Calbiochem, Billerica, Massachusetts, USA) before staining. These inhibitors were used at the indicated concentrations as previously described ([@bib2]; [@bib3]; [@bib75]).

Reconstituted 3D human epidermis inhibitor treatment {#s4-9}
----------------------------------------------------

Reconstituted 3D epidermis (LabCyte EPI-MODEL) derived from cultured human epidermal keratinocytes was purchased from J-TEC (Aichi, Japan). Prior to pharmacological treatment, the reconstituted epidermis was cultured in the medium for 12 hr according to the manufacturer's protocol. The treatment details were as described in ex-vivo inhibitor treatment.

Quantitative RT-PCR (qRT-PCR) {#s4-10}
-----------------------------

RNA was extracted from whole paw skin using the RNeasy Mini kit (QIAGEN), and the cDNA was prepared using the SuperScript III First-Strand Synthesis System (Thermo Fisher Scientific). The qRT-PCR was performed using the designated primers and fast SYBR Green (Thermo Fisher Scientific) in a STEP-One Plus sequence detection system (Applied Biosystems, Waltham, Massachusetts, USA). All the primers used in this study are listed in [Table 1](#tbl1){ref-type="table"}.10.7554/eLife.26635.021Table 1.Primers used in qRT-PCR.**DOI:** [http://dx.doi.org/10.7554/eLife.26635.021](10.7554/eLife.26635.021)Gene nameForward (5′→3′)Reverse (5′→3′)*mTcf7l1*TGGTCAACGAATCGGAGAATTCACTTCGGCGAAATAGTCG*mTcf7l2*CTCCACAGCTCAAAGCATCACACCACCTTCGCTCTCATCT*mLef1*CGCTAAAGGAGAGTGCAGCTAGCTGTCTCTCTTTCCGTGCT*mTcf7*GCCAGAAGCAAGGAGTTCACACTGGGCCAGCTCACAGTAT*mCtnnb1*AAGGCTTTTCCCAGTCCTTCCCCTCATCTAGCGTCTCAGG*mFzd7*GACCAAGCCATTCCTCCGTGCAGGTAGGGAGCAGTAGGGTA*mFzd4*AACCTCGGCTACAACGTGACGGCACATAAACCGAACAAAGGAA*mNfatc4*CAAGCTGCGAGGATGAGGAGACAGCATGGAGGGGTATCCT*mWnt4*GTCAGGATGCTCGGACAACATCACGTCTTTACCTCGCAGGA*mWnt5a*GGACCACATGCAGTACATTGGCGTCTCTCGGCTGCCTATTT*mFzd3*TGATGAGCCATATCCCCGACTGCCTATGAAATAGCGAGCAAATG*mFzd8*CCGCTGGTGGAGATACAGTGCGGTTGTAGTCCATGCACAG*mItga6*ATGCCACCTATCACAAGGCTGCATGGTATCGGGGAATGCT*mItgb1*ATCATGCAGGTTGCGGTTTGTGGAAAACACCAGCAGTCGT*mTgm1*TTTGATGGGTGGCAGGTTGTGCCATTCTTGACGGACTCCA*mCol17*GATGGCACTGAAGTCACCGATATCCATTGCTGGTGCTCCC*mPpl*GCATGCTGAGTGGAAGGAGTAAGTCTGAGTCCACCTTGCG*mEvpl*TCCTACAAGCTGCAAGCACATCTAAGGAGCAGCGGTAGGT*mIvl*CTCCTGTGAGTTTGTTTGGTCTCACACAGTCTTGAGAGGTCCC*mCyc1*ATCGTTCGAGCTAGGCATGGGCCGGGAAAGTAAGGGTTGA*mGusb*CAGGGTTTCGAGCAGCAATGACCCAGCCAATAAAGTCCCG*mGapdh*TCCTGCACCACCAACTGCTTAGCTGGATGCAGGGATGATGTTCTGG*hCOL17*TCAACCAGAGGACGGAGTCATCGACTCCCCTTGAGCAAAC*h18S*GGCGCCCCCTCGATGCTCTTAGGCTCGGGCCTGCTTTGAACACTCT

Barrier function assay {#s4-11}
----------------------

An in situ skin permeability assay using Toluidine blue was performed as previously described ([@bib19]). Transepidermal water loss (TEWL) of the embryo back skin was measured using an evaporimeter (AS-VT100RS;Asahi Biomed, Tokyo, Japan) ([@bib76]).

Transmission electron microscopy {#s4-12}
--------------------------------

Biopsy samples from paw skin specimens were fixed in 2% glutaraldehyde solution, post-fixed in 1% OsO~4~, dehydrated, and embedded in Epon 812. The embedded samples were sectioned at 1 µm thickness for light microscopy and thin-sectioned for electron microscopy (70 nm thick). The thin sections were stained with uranyl acetate and lead citrate and examined by transmission electron microscopy (H-7100; Hitachi, Tokyo, Japan).

*COL17A1* knockdown and cell proliferation assay on normal human epidermal keratinocytes {#s4-13}
----------------------------------------------------------------------------------------

Normal human epidermal keratinocytes (NHEKs, Lonza) in passages 3--4 were seeded with KGM-Gold (Lonza) in a 96-well plastic bottom plate. The cells were transfected with 10 μM of either human *COL17A1* siRNAs or the control (Mock) (Silencer Select siRNAs, Thermo Fisher, Waltham, Massachusetts, USA) using RNAimax (Thermo Fisher) and Opti-MEM (Thermo Fisher). Cell growth curves were generated using an xCELLigence system (ACEA bioscience, San Diego, California, USA, RRID:[SCR_014821](https://scicrunch.org/resolver/SCR_014821)) at 24 hr after the knockdown procedure.

For the colony formation assay, 1000 cells/ml of NHEKs (passages 3--4) were seeded in 6-well plates on mitomycin C (Wako, Osaka, Japan) treated 3T3-J2 feeder cells (RRID:[CVCL_W667](https://scicrunch.org/resolver/CVCL_W667)) and were transfected with either *COL17A1* siRNA or mock siRNA, as described above. Cells were maintained in KGM-Gold with 10% fetal bovine serum (Sigma-Aldrich, St. Louis, Missouri, USA) for 2 weeks. To detect the colonies, cells were fixed with 4% paraformaldehyde for 10 min and stained for 20 min with 1% rhodamine (Sigma-Aldrich) diluted in distilled water. The colony number and size were analyzed by ImageJ (NIH, Bethesda, Maryland, USA). All the cells used in this assay were subject to regular mycoplasma testing.

Immunoblotting {#s4-14}
--------------

Cultured cells were collected and lysed in 1% NP-40-containing buffer. The samples were loaded on a NuPAGE 4--12% Bis-Tris gel (Thermo Fisher) and then transferred to a PVDF membrane. The membrane was incubated with primary antibodies (anti-C-terminal region of human COL17 (09040) [(]{.ul}[@bib70]) and anti-beta tubulin (Abcam, Cambridge, UK, RRID:[AB_2210370](https://scicrunch.org/resolver/AB_2210370))) followed by secondary antibodies conjugated with horseradish peroxidase. The blots were detected using ECL-Plus (GE Healthcare).

Subjects with JEB {#s4-15}
-----------------

Skin samples from two patients with the generalized other subtype of JEB were used in this study. The JEB patients harbored truncation mutations in COL17A1, and their skin specimens were negative for COL17 expression [(]{.ul}[@bib45])(Masuda et al., manuscript in preparation). The patients were a newborn Japanese male and a 15-year-old Japanese male. As controls for the immunofluorescence staining, skin samples were collected from age-, site-, and sex-matched healthy individuals.

Gene expression microarray {#s4-16}
--------------------------

The total RNA extracted from young (6- to 10-week-old) and aged (19- to 27-month-old) mouse whole paw skin was hybridized to an Agilent SurePrint G3 Mouse v2 8 × 60K 1 color 8 microarray. N = 4 for each group. The microarray data were analyzed using GeneSpring software (Agilent Technology, Santa Clara, California, USA, RRID:[SCR_009196](https://scicrunch.org/resolver/SCR_009196)).

Data availability {#s4-17}
-----------------

Microarray data are available in the ArrayExpress database ([www.ebi.ac.uk/arrayexpress](http://www.ebi.ac.uk/arrayexpress), RRID:[SCR_002964](https://scicrunch.org/resolver/SCR_002964)) under accession number E-MTAB-4916.

In silico model {#s4-18}
---------------

The authors Y. K. and M. N. previously introduced a mathematical model that could simulate the homeostasis of the epidermis ([@bib26]). In this model, the four epidermal processes were taken into account: (i) the kinetic interactions of epidermal cells, (ii) the reproduction of stem cells and daughter cells, (iii) differentiation, and (iv) calcium dynamics. Migration of the cells after leaving the basal layer was naturally realized by the hard-core repulsive interactions among the cells, and the differentiation process was controlled by the calcium dynamics.

Numerical investigation of the model revealed that because of the calcium dynamics, the thickness of the epidermis was maintained, and the lower boundary of the stratum corneum retained a flat structure.

For the present purpose, we modified this model in such a way that we could investigate the effect of the binding strength of the stem cells to the basal membrane. The kinetic interactions and the reproduction process were modified as follows.

Each cell was represented as a sphere characterized by its position $x_{i} = \left( x_{i},~y_{i},~z_{i} \right)$ and radius $R$. The basal membrane was modeled as a monolayer of densely packed immobile particles, each having the radius$~R_{m}$. The cells obeyed the following equations of motion:$$\mu\ \frac{dx_{i}}{dt} = - \frac{\partial}{\partial x_{i}}\left( {\sum\limits_{j \in \Omega_{LJ}}V_{LJ}\left( {|x_{i} - x_{j}|} \right) + \sum\limits_{j \in \Omega_{m}}V_{m}\left( {|x_{i} - x_{j}|} \right)} \right),$$

where $\mu$ is the coefficient of friction; $V_{LJ}$ is the repulsive interaction between cell $i$ and cell $j$, which is either one of the adjacent cells or the nearest membrane particle; and $V_{m}$ is the interaction with the membrane. The interactions were considered only for the particles that are in contact with cell $i$. The first summation was taken over the set $\Omega_{LJ}$, which consists of both cells and membrane particles, and the second summation was over $\Omega_{m}$, which contains only the membrane particles.

The first potential was given by$$V_{LJ}\left( r \right) = \varepsilon\left\{ {\left( \frac{R + R_{j}}{r} \right)^{6} - \frac{1}{2}\left( \frac{R + R_{j}}{r} \right)^{12}} \right\},$$

where $\varepsilon$ is a positive constant. If cell $j$, interacting with $i$, represented the epidermal cell, then $R_{j} = R$, and if cell $j$ is the membrane particle, then$~R_{j} = R_{m}$. The second potential $V_{m}$ was assumed to be cell-dependent. For the suprabasal cells, $V_{m} = 0$; for the stem cells, the interaction was spring-like:$$V_{m}\left( r \right) = \frac{K_{s}}{2}\left\{ {(r - (R + R_{m})} \right\}^{2},$$

where $K_{s}$ is a positive constant. For the daughter cells, it was assumed to be a nonlinear spring:$$V_{m}\left( r \right) = \left\{ \begin{matrix}
{\frac{K_{d}}{2}\left\lbrack {a\left\{ {(r - \left( {R + R_{m}} \right)} \right\}^{2} - \frac{b}{2}\left\{ {(r - \left( {R + R_{m}} \right)} \right\}^{4}} \right\rbrack} \\
{\qquad\qquad\qquad\qquad 0\qquad(r\  > \ r^{\ast}),} \\
\end{matrix} \right.\!(r \leq r^{\ast}),$$

where $K_{d}$, $a$, and $d$ are positive constants and $r^{*} = R + R_{m} + \sqrt{a/b}$. That is, the daughter cells could leave the basal layer when the distance became greater than the threshold $r^{*}$, while the stem cells were bound to the basal membrane and could not leave it.

The cell reproduction process was modeled in the following way: each reproducible cell was assigned a deterministic cell cycle with the period $T$. After the period elapsed, the cell entered into the stochastic division process, which was the Poisson process with the rate $\gamma$.

When the division of cell $i$ started, the new particles $j$ and $k$ were created with the radius $R$ at the same place as cell $i$, with cell $i$ itself deleted: $x_{j}\left( t_{0} \right) = x_{k}\left( t_{0} \right) = x_{i}\left( t_{0} \right)$. Note that the overlapping of $j$ and $k$ was allowed. The force exerted on $j$ by $k$ was given as the partial derivative $- \frac{\partial}{\partial x_{j}}$ of the following elastic potential:$$U\left( \left| {x_{j} - x_{k}} \right| \right) = \frac{K^{'}}{2}\left( {\left| {x_{j} - x_{k}} \right| - l\left( t \right)} \right)^{2},$$

where $K^{'}$ is a positive constant and $l\left( t \right)$ is the natural distance between $j$ and $k$, which linearly increases as $l\left( t \right) = \alpha\left( t - t_{0} \right)$ with a constant $\alpha$. When $l\left( t \right)$ reached $l\left( t \right) = 2R$, the division was considered to be completed, and the potential $U$ was no longer computed.

The differentiation processes and calcium dynamics were the same as in the manuscript ([@bib26]), which were summarized as follows: each suprabasal cell was assigned a degree of differentiation $S$ as an internal variable. When $S$ reached the threshold $S^{*}$, the cell underwent terminal differentiation and became a cornified cell. The advancement of $S$ was accelerated when the calcium concentration of the cell was high, and calcium excitation was induced when the cell was in contact with the cornified cells, reflecting the fact that high-calcium concentration was observed beneath the stratum corneum.

We numerically solved this model with the following initial conditions. According to previous results, we first obtained the steady states of the epidermis with an undulated basal membrane. We used these states as initial conditions. For each of five different initial conditions, we decreased the binding strength, $K_{d}$, to the basal membrane from $K_{d} = 5.0$ to $K_{d} = 2.0$ and ran simulations. For comparison, we also ran simulations for each of the initial conditions without changing $K_{d} = 5.0$. Other parameters were chosen: $\mu = 1.0$, $R = 1.4$, $R_{m} = 1.0$, $\varepsilon = 1.0$, $K_{s} = 25.0$, $a = 0.0868$, $b = 0.376$, $K' = 5.0$, $\gamma = 0.00813$, and $\alpha = 0.14$. By choosing these parameters and others used in the previous work \[1\], we assumed that the average cell division and turnover periods were approximately 3 and 28 days, respectively.

[Figure 1F](#fig1){ref-type="fig"} shows the ratio of the epidermis to its initial value. Each curve represents the ensemble average of five independent simulations with different shapes of the basal membrane.

Statistical analysis {#s4-19}
--------------------

Statistical analysis was performed using GraphPad Prism (GraphPad Software, La Jolla, California, USA, RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)). p-Values were determined using Student's t-test, the Mann-Whitney test or one-way ANOVA followed by Tukey's test. p-Values are indicated as \*0.01\<p\<0.05, \*\*0.001\<p\<0.01, \*\*\*0.0001\<p\<0.001, \*\*\*\*p\<0.0001. The values are shown as the means ± standard errors (SE). Sample size for animal experiments was determined on the basis of pilot experiments.
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\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"Type XVII collagen coordinates proliferation in the interfollicular epidermis\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Reviewing Editor Johanna Ivaska and a Senior Editor. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered for publication in *eLife* at this stage.

All the reviewers found your study to be of high quality, interesting and potentially suitable for publication in *eLife*. The reviewers especially valued the novelty of the manuscript demonstrating the role of COL17 in the homeostasis of the interfollicular epidermis. The data linking loss of COL17 to hyperproliferation and altered Wnt signalling were considered to be important and of interest. In addition, the link between aging and reduced COL17 level, resulting in hyperproliferation similar to the COL17 loss phenotype, were appreciated by the reviewers as they provide novel insights into understanding epidermal changes during skin aging.

However, there were some major concerns that need to be addressed and given their extent we found it unlikely that these can be addressed in the 2 month time window allowed for revisions in *eLife*. However, we would be happy to evaluate a new submission fully addressing the concerns of the reviewers. Based on the online discussion especially the following points are essential (but also other reviewer concerns should be considered).

The reviewers find that the link between WNT signalling and the phenotype are not solid enough and it needs to be validated in more detail:

Reviewer \#2: The studies in [Figure 2](#fig2){ref-type="fig"} showing that COL17 regulates neonatal IFE proliferation through Wnt signaling are descriptive. The involvement of Wnt signaling in COL17-deficient proliferative IFE phenotype needs to be demonstrated in vitro and/or in vivo\" and Reviewer\#1: The link between reduced Wnt signaling and hyperproliferation is surprising, as most of the literature associate Wnt as a pro proliferative signal in the epidermis (see for example (Lim et al., Science 2013). On the other hand Lef1 has been shown to be reduced as part of the skin inflammatory response (Quigley et al., Cell Reports 2016 PMID: 27425619). Given this, the causative link between Collagen XVII loss, suppression of Wnt and subsequent hyperproliferation should be more firmly demonstrated. Data showing that the K14-ΔNLef mouse has a similar phenotype is correlative at best, especially since it is not completely clear how this transgene regulates Wnt signaling. I realize that a rescue experiment with overexpression of a Wnt pathway component is time consuming, but perhaps an in vitro rescue or injection of a Gsk-3beta inhibitor\"

Another major concern was related to the loss of the phenotype in the mice with age:

Reviewer\#2: [Figure 1](#fig1){ref-type="fig"} showed epidermal hyperproliferation was observed in the neonates of *Col17a1 -/-* mice. The authors need to explain and clarify why the proliferative IFE phenotype of *Col17a1 -/-* mice gradually weaned. In addition, the authors need to examine the skin of different regions to confirm if epidermis was hyperproliferative in region-specific manner.\"

Reviewer\#3: Results, subsection "COL17 regulates neonatal IFE proliferation through Wnt-β-catenin signaling": The authors find that the immunostaining of LEF1, β-catenin and PH3 are changed in the skin biopsies of two JEB patients with COL17A1 null mutations in a similar way to newborn *Col17a1-/-* mice. However, in the *Col17a1-/-* mice these changes are transient, but not in human. What is the explanation for this finding? Was there hyperproliferation in JEB epidermis?\"

The Discussion was found to be two speculative and this need to be revised:

Reviewer\#2: Discussion: The authors should discuss how their results are applied to human skin ie: What are the limitations of their study.

Discussion, paragraph six. I found this chapter highly speculative and I would suggest to re-write it. It is known that collagen XVII is involved in squamous cell carcinoma and recent papers have suggested its importance in colon and lung cancer (Moilanen et al., 2015, Liu et al., 2016 and 2016a). Moreover, I would not state that JEB patients with COL17A1 mutations have high frequency of multiple cutaneous SCC. In the paper by Yuen and Jonkman, only 2 out 14 JEB patients who developed SCC, were carriers of COL17A1 mutations. In addition, in the US National EB registry, the frequency of SCC in non-Herlitz JEB patients was very low (Fine et al., 2009).

Reviewer\#3: The authors stated the possible role of COL17 in the prevention of oncogenesis in the Discussion but didn\'t provide any evidence for that. The authors need to study it in detail or tone down the statements.

Reviewer \#1 had concerns regarding the statistics.

Reviewer \#1:

This is an interesting manuscript on the role of type XVII in the interfollicular epidermis. The authors show that deletion of Col XVII results in a transient hyperproliferative responsem which the authors attribute to reduced cell adhesion and attenuated Wnt signaling. They further show that Col XVII is reduced during aging, resulting in hyperproliferation.

There are several interesting elements in the manuscript and the data is overall of good quality. The causative links between the observations are, however, not completely clear and should in my opinion be more firmly established prior to publication.

1\) Collagen XVII is a critical adhesion molecule in the epidermis, highlighted by its involvement in human blistering disease. The authors should assess potential blistering and basement membrane integrity in there model in more detail by higher resolution imaging and preferably also EM. They should further exclude presence of inflammation at sites of \"reduced attachment\" that is almost invariably associated with disruption of the basement membrane, as this could be the cause of a transient hyperproliferative response.

2\) Can the hyperproliferation phenotype be detected in isolated keratinocytes? This would provide further proof for a cell autonomous signaling defect.

3\) The link between reduced Wnt signaling and hyperproliferation is surprising, as most of the literature associate Wnt as a pro proliferative signal in the epidermis (see for example (Lim et al., 2013). On the other hand Lef1 has been shown to be reduced as part of the skin inflammatory response (Quigley et al., Cell Reports 2016 PMID: 27425619). Given this, the causative link between Collagen XVII loss, suppression of Wnt and subsequent hyperproliferation should be more firmly demonstrated. Data showing that the K14-ΔNLef mouse has a similar phenotype is correlative at best, especially since it is not completely clear how this transgene regulates Wnt signaling. I realize that a rescue experiment with overexpression of a Wnt pathway component is time consuming, but perhaps an in vitro rescue or injection of a Gsk-3beta inhibitor.

4\) In their discussion, the authors attribute the discrepant outcomes of altered Wnt (hypo vs hyperproliferation) to different anatomical locations (paw versus back skin). This could be easily tested by analyzing paw skin in their mouse model.

5\) As the authors themselves point out, several reports have shown epidermal thinning during aging and this seems also to be the case in human aging. The authors should more critically discuss this discrepancy in the Discussion section and also perhaps mention the critical role of extrinsic factors such as the hygiene status of the animal housing facility that might influence this phenotype.

6\) The exact n number used for the quantifications should be included in the figure legends. In addition, the statistics seem inappropriate as it is not clear why a parametric test (Students-t) is used in cases where the data is unlikely to have equal variance and normal distribution (for example IF analyses of data from 3 mice). A more appropriate test such as the Mann-Whitney U test should be applied.

Reviewer \#2:

The authors examined the role of COL17 in regulating IFE homeostasis. How aging influences the homeostasis of the IFE and its stem cells has been elusive. This manuscript tackles this important issue. The data are in most parts beautiful. The study will provide novel insights into understanding epidermal changes during skin aging. There are additional experiments and discussions the authors can add to improve the manuscript.

1\) [Figure 1](#fig1){ref-type="fig"} showed epidermal hyperproliferation was observed in the neonates of *Col17a1 -/-* mice. The authors need to explain and clarify why the proliferative IFE phenotype of *Col17a1 -/-* mice gradually weaned. In addition, the authors need to examine the skin of different regions to confirm if epidermis was hypeproliferative in region-specific manner.

2\) The studies in [Figure 2](#fig2){ref-type="fig"} showing that COL17 regulates neonatal IFE proliferation through Wnt signaling are descriptive. The involvement of Wnt signaling in COL17-deficient proliferative IFE phenotype needs to be demonstrated in vitro and/or in vivo.

3\) Interestingly, the treatment of young mouse IFE samples with PKC inhibitor diminished apico-lateral membraneous COL17. To confirm if the changes of COL17 distribution were α-PKC-dependent, the authors need to confirm the level of phospho-PKC α in the IFE samples treated with Go6983 and myr PSI.

4\) The authors stated the possible role of COL17 in the prevention of oncogenesis in the discussion but didn\'t provide any evidence for that. The authors need to study it in detail or tone down the statements.

Reviewer \#3:

In this manuscript the authors present convincing data that suggest a novel role to transmembrane collagen XVII to regulate the proliferation of interfollicular epidermis (IFE) in murine skin. They show that the lack of collagen XVII leads to transient IFE proliferation in the paw skin of neonatal *Col17a1-/-* mice. Analyzes of signaling pathways reveals that the IFE proliferation is mediated by the suppression of Wnt signaling. Accordingly, the immunostaining of LEF1 and β-catenin are decreased in basal cells of *Col17a1-/-* mice epidermis and also in skin biopsies obtained from newborn and 15-year-old JEB patient who carry COL17A1 null mutations. Transgenic rescue by the expression of human collagen XVII in *Col17a1-/-* mice abrogates IFE hypeproliferation and altered Wnt signaling. They further demonstrate that physical aging leads to IFE hyperproliferation in mice and at the same time, the amount of non-hemidesmosomal collagen XVII is reduced in both mice and human skin. Moreover, physical aging related changes of the calcium concentration of keratinocytes and the reduction of atypical protein kinase C (αPKC) contribute to the distribution of collagen XVII in aging IEF. Finally, overexpression of human collagen XVII suppresses the epidermal hyperproliferation with physical aging of IFE.

The study is of a great interest since it suggest a novel function of collagen XVII as an anti-aging molecule of the skin. However, I have some comments addressing the methodological aspects and interpretation of results.

1\) Introduction, paragraph three: I would not call lamina lucida and lamina densa as components of basement membrane, since especially lamina lucida is generally considered as an artifact of tissue dehydration.

2\) Introduction: Please add a recent study which suggests that the expression of collagen XVII is decreased in aged human skin (Langton et al., 2016). Please also discuss this paper.

3\) Results, first paragraph: For readers who are not familiar with cutaneous biology, the authors could clarify the relationship between the murine paw skin and human skin.

4\) Results, second paragraph: Why the expression of integrin β 2 and the three chains of laminin 332 were not measured?

5\) Results, subsection "COL17 regulates neonatal IFE proliferation through Wnt-β-catenin signaling ": The authors find that the immunostaining of LEF1, ββ-catenin and PH3 are changed in the skin biopsies of two JEB patients with COL17A1 null mutations in a similar way to newborn *Col17a1-/-* mice. However, in the *Col17a1-/-* mice these changes are transient, but not in human. What is the explanation for this finding? Was there hyperproliferation in JEB epidermis?

6\) Results, subsection "Distribution of COL17 is altered with physical aging": Is there hyperproliferation of epidermis in aging human skin?

7\) Results, Subsection "Atypical PKC controls the distribution of COL17 in IFE": Does the treatment of skin samples with EDTA really simulate aged IFE or rather the changes of calcium concentration in aged skin?

8\) Discussion. The authors should discuss how their results are applied to human skin ie; What are the limitations of their study.

9\) Discussion, paragraph six. I found this chapter highly speculative and I would suggest to re-write it. It is known that collagen XVII is involved in squamous cell carcinoma and recent papers have suggested its importance in colon and lung cancer (Moilanen et al.,2015, Liu et al., 2016 and 2016a). Moreover, I would not state that JEB patients with COL17A1 mutations have high frequency of multiple cutaneous SCC. In the paper by Yuen and Jonkman, only 2 out 14 JEB patients who developed SCC, were carriers of COL17A1 mutations. In addition, in the US National EB registry, the frequency of SCC in non-Herlitz JEB patients was very low (Fine et al., 2009).

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Type XVII collagen coordinates proliferation in the interfollicular epidermis\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Anna Akhmanova (Senior editor), a Reviewing editor, and two of the original three reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

The manuscript has improved as the link between col17 and Wnt has been better established (Wnt inhibitors, Top-gal), although especially the Top gal images don\'t look completely convincing regarding the selection of the area that is being measured. It would be better to have an unbiased approach for this.

However, at the same time the manuscript has become somewhat confusing: on one hand luciferase assays demonstrate that the Wnt defect is maintained in cell culture, on the other hand the proliferation phenotype is not present. What is the explanation for this? In addition, on one hand there are similarities in human and mouse skin but the keratinocytes show an opposite effect regarding proliferation.

In addition to this fundamental issue, many of the discrepancies in the data are dismissed by discussion instead of attempting to tackle them experimentally.

If the epidermal structure (and not a minor barrier defect) is really the underlying factor, analysis of organotypic raft cultures should recapitulate the phenotype. Alternatively, the authors are welcome to consider other experimental approaches to address this.

10.7554/eLife.26635.026

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

All the reviewers found your study to be of high quality, interesting and potentially suitable for publication in eLife. The reviewers especially valued the novelty of the manuscript demonstrating the role of COL17 in the homeostasis of the interfollicular epidermis. The data linking loss of COL17 to hyperproliferation and altered Wnt signalling were considered to be important and of interest. In addition, the link between aging and reduced COL17 level, resulting in hyperproliferation similar to the COL17 loss phenotype, were appreciated by the reviewers as they provide novel insights into understanding epidermal changes during skin aging.

However, there were some major concerns that need to be addressed and given their extent we found it unlikely that these can be addressed in the 2 month time window allowed for revisions in eLife. However, we would be happy to evaluate a new submission fully addressing the concerns of the reviewers. Based on the online discussion especially the following points are essential (but also other reviewer concerns should be considered).

The reviewers find that the link between WNT signalling and the phenotype are not solid enough and it needs to be validated in more detail:

Reviewer \#2: The studies in [Figure 2](#fig2){ref-type="fig"} showing that COL17 regulates neonatal IFE proliferation through Wnt signaling are descriptive. The involvement of Wnt signaling in COL17-deficient proliferative IFE phenotype needs to be demonstrated in vitro and/or in vivo\" and Reviewer\#1: The link between reduced Wnt signaling and hyperproliferation is surprising, as most of the literature associate Wnt as a pro proliferative signal in the epidermis (see for example (Lim et al., 2013). On the other hand Lef1 has been shown to be reduced as part of the skin inflammatory response (Quigley et al., Cell Reports 2016 PMID: 27425619). Given this, the causative link between Collagen XVII loss, suppression of Wnt and subsequent hyperproliferation should be more firmly demonstrated. Data showing that the K14-ΔNLef mouse has a similar phenotype is correlative at best, especially since it is not completely clear how this transgene regulates Wnt signaling. I realize that a rescue experiment with overexpression of a Wnt pathway component is time consuming, but perhaps an in vitro rescue or injection of a Gsk-3beta inhibitor\"

To further validate the relationship between Wnt signaling and COL17, we performed three key experiments ([Figure 2D, E and G](#fig2){ref-type="fig"}) as follows:

a\) The modified TOPFLASH reporter assay using HEK293 cells (Tsukiyama et al., 2015) revealed that COL17 expression stabilizes Wnt activity in vitro ([Figure 2D](#fig2){ref-type="fig"}).

b\) Crossing of ins-TOPGAL mice (a Wnt reporter animal) with *Col17a1*-/- showed that the absence of COL17 diminishes Wnt activity in paw IFE cells in vivo ([Figure 2E](#fig2){ref-type="fig"}).

c\) Intraperitoneal administration of two Wnt inhibitors (IWP-2 and Wnt-C59) into neonatal mice resulted in paw IFE hyperproliferation in P1 mice ([Figure 2G](#fig2){ref-type="fig"}), which reproduced the result of the deltaNLef mice ([Figure 2F](#fig2){ref-type="fig"}). This is contrasted by the IFE hypotrophy in the paw of 1-month-old mice with inducible loss-of-function of β-catenin (Lim et al., 2013). We believe that this discrepancy is due to the differences of observational time points (neonate vs 1-month-old) and/or in the systems used in each study (conventional vs inducible loss-of-function).

Taken together, these results strongly corroborate the substantial link between COL17 and Wnt signaling associated with paw IFE proliferation at P1.

Another major concern was related to the loss of the phenotype in the mice with age:

Reviewer\#2: [Figure 1](#fig1){ref-type="fig"} showed epidermal hyperproliferation was observed in the neonates of Col17a1 -/- mice. The authors need to explain and clarify why the proliferative IFE phenotype of Col17a1 -/- mice gradually weaned. In addition, the authors need to examine the skin of different regions to confirm if epidermis was hyperproliferative in region-specific manner.\"

Our mathematical models of epidermal development have predicted that, upon the loosening of the attachment of committed progenitor cells to the basement membrane zone, the epidermal thickness was transiently increased and gradually returned to the baseline ([Figure 1F](#fig1){ref-type="fig"}), which was compatible with our observation of Col17a1-/- neonatal epidermis and with the similar transient hypertrophy of Itga6-/- and Itgb1-/- epidermis (Brakebusch et al., 2000; Niculescu C et al., 2011). We believe that transient epidermal hyperproliferation with gradual weaning is at least partially explained by the loosening of dermo-epidermal adhesion at the neonatal stage. In addition, our observations of deltaNLef ([Figure 2F](#fig2){ref-type="fig"}) and Wnt-inhibitor treated mice ([Figure 2G](#fig2){ref-type="fig"}) showed that inactive Wnt signaling leads to IFE proliferation in the paw skin of P1 mice. As the number of LEF1-positive cells in the *Col17a1-/-* paw IFE was comparable with that of control mice by P4, we reasoned that the effect of inactive Wnt signaling on epidermal proliferation in *Col17a1-/-* epidermis at P1 is reset at P4, although the detailed mechanisms of this transient effect remain elusive. We included this notion in the revised manuscript.

Quantification of proliferation markers in the back skin IFE from P1 *Col17a1-/-* and control mice showed no significant differences ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}), confirming the site specificity of these cell dynamics. We suspect that this discordance between the paw epidermis and back skin IFE might be explained either by the influence of hair follicle development on back skin IFE at P1 (generally in stage 5) or by the distinct regulation of IFE at each location in the body (Rompolas et al., 2016, Roy et al., 2016, Sada et al., 2016). We have included this discussion in the revised manuscript.

*Reviewer\#3: Results, subsection "COL17 regulates neonatal IFE proliferation through Wnt-β-catenin signaling": The authors find that the immunostaining of LEF1, β-catenin and PH3 are changed in the skin biopsies of two JEB patients with COL17A1 null mutations in a similar way to newborn Col17a1-/- mice. However, in the Col17a1-/- mice these changes are transient, but not in human. What is the explanation for this finding? Was there hyperproliferation in JEB epidermis?\"*

We admit that the sample size of JEB patients is too small to draw a definitive conclusion. However, as JEB patients with COL17A1 mutations are very rare and it is difficult to obtain samples from these patients, we cannot increase the sample size. We have no data on why the changes seen in *Col17a1-/-* mice are transient but are not in human JEB skin. We have added this limitation to the revised manuscript and moved the JEB patient data from the main figures to the supporting materials ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

The Discussion was found to be two speculative and this need to be revised:

Reviewer\#2: Discussion: The authors should discuss how their results are applied to human skin ie: What are the limitations of their study.

In light of chronic stimuli and non-UV exposure, it would be reasonable to state that the murine paw IFE may be equivalent to the human palmoplantar and buttock epidermis. We have included this information in the revised manuscript.

In addition, we have listed the limitations of our study in the revised manuscript as follows:

a\) Chronic stimulation through ambulation might affect paw IFE homeostasis with physical aging.

b\) Drug-induced aPKC inhibition on the epidermis may not completely exclude non-specific pharmacological effects.

c\) Our strategy did not utilize the inducible expression or deletion of COL17.

Discussion, paragraph six. I found this chapter highly speculative and I would suggest to re-write it. It is known that collagen XVII is involved in squamous cell carcinoma and recent papers have suggested its importance in colon and lung cancer (Moilanen et al., 2015, Liu et al., 2016 and 2016a). Moreover, I would not state that JEB patients with COL17A1 mutations have high frequency of multiple cutaneous SCC. In the paper by Yuen and Jonkman, only 2 out 14 JEB patients who developed SCC, were carriers of COL17A1 mutations. In addition, in the US National EB registry, the frequency of SCC in non-Herlitz JEB patients was very low (Fine et al., 2009).

Reviewer\#3: The authors stated the possible role of COL17 in the prevention of oncogenesis in the discussion but didn\'t provide any evidence for that. The authors need to study it in detail or tone down the statements.

We have toned down and extensively rewritten this section in the Discussion, as well as cited and discussed the papers according to the reviewer's suggestion. In addition, we have deleted the statement that JEB patients with COL17A1 mutations have a high frequency of multiple cutaneous SCC in the revised manuscript.

Reviewer \#1 had concerns regarding the statistics.

In accordance with the reviewer's suggestion, we included the exact n number used for each experiment in the figure legends. In the revised manuscript, we also applied the Mann-Whitney test to the data, which were unlikely to have equal distribution (e.g., relative fluorescent intensity).

Reviewer \#1:

This is an interesting manuscript on the role of type XVII in the interfollicular epidermis. The authors show that deletion of Col XVII results in a transient hyperproliferative responsem which the authors attribute to reduced cell adhesion and attenuated Wnt signaling. They further show that Col XVII is reduced during aging, resulting in hyperproliferation.

There are several interesting elements in the manuscript and the data is overall of good quality. The causative links between the observations are, however, not completely clear and should in my opinion be more firmly established prior to publication.

1\) Collagen XVII is a critical adhesion molecule in the epidermis, highlighted by its involvement in human blistering disease. The authors should assess potential blistering and basement membrane integrity in there model in more detail by higher resolution imaging and preferably also EM. They should further exclude presence of inflammation at sites of \"reduced attachment\" that is almost invariably associated with disruption of the basement membrane, as this could be the cause of a transient hyperproliferative response.

EM images of *Col17a1-/-* mouse back skin were published by our group (Nishie et al., 2007). According to the reviewer's suggestion, we examined the paw skin of P1 *Col17a1-/-* mice using EM ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). The result showed hypoplastic hemidesmosomes and blurred anchoring filaments, as reported in the back skin, suggesting disturbed integrity of the basement membrane zone in the *Col17a1*-/- paw epidermis.

We confirmed that there were no significant differences in the number of dermal immune infiltrates (i.e., T-cells, macrophages and neutrophils) in the paw skin between *Col17a1-/-* mice and control mice ([Figure 1---figure supplement 1E-G](#fig1s1){ref-type="fig"}), thus excluding the involvement of inflammatory processes in the disorganization of the basement membrane zone in *Col17a1*-/- skin.

2\) Can the hyperproliferation phenotype be detected in isolated keratinocytes? This would provide further proof for a cell autonomous signaling defect.

The isolated keratinocytes from *Col17a1-/-* neonatal epidermis from the whole body were shown to be less proliferative in the colony formation assay (Tanimura et al., 2011) as opposed to the in vivo IFE hyperproliferation of keratinocytes from *Col17a1*-/- neonates. To confirm the previous data, we tested several proliferation assays on normal human epidermal keratinocytes (NHEKs) treated with *COL17A1* siRNAs ([Figure 1---figure supplement 2B-F](#fig1s2){ref-type="fig"}). These assays revealed that the proliferative potential of NHEKs treated with *COL17A1* siRNAs is not significantly different from that of the control cells. These data suggest that the hyperproliferation of the *Col17a1*-/- paw IFE in P1 mice is dependent on in vivo conditions.

3\) The link between reduced Wnt signaling and hyperproliferation is surprising, as most of the literature associate Wnt as a pro proliferative signal in the epidermis (see for example (Lim et al., 2013). On the other hand Lef1 has been shown to be reduced as part of the skin inflammatory response (Quigley et al., Cell Reports 2016 PMID: 27425619). Given this, the causative link between Collagen XVII loss, suppression of Wnt and subsequent hyperproliferation should be more firmly demonstrated. Data showing that the K14-ΔNLef mouse has a similar phenotype is correlative at best, especially since it is not completely clear how this transgene regulates Wnt signaling. I realize that a rescue experiment with overexpression of a Wnt pathway component is time consuming, but perhaps an in vitro rescue or injection of a Gsk-3beta inhibitor.

Please see the response to the Editor.

4\) In their Discussion, the authors attribute the discrepant outcomes of altered Wnt (hypo vs hyperproliferation) to different anatomical locations (paw versus back skin). This could be easily tested by analyzing paw skin in their mouse model.

Please see the response to the Editor.

5\) As the authors themselves point out, several reports have shown epidermal thinning during aging and this seems also to be the case in human aging. The authors should more critically discuss this discrepancy in the Discussion section and also perhaps mention the critical role of extrinsic factors such as the hygiene status of the animal housing facility that might influence this phenotype.

To explain the discrepancy in the epidermal growth rate with aging (hyperproliferation in our studies and others (Stern and Bickenbach, 2007; Charruyer et al., 2009) vs hypoproliferation (Giangreco, Qin, Pintar and Watt, 2008)), we propose the following confounding factors (including the hygiene status as the reviewer noted) and discussed these factors in the revised manuscript:

a\) UV exposure (which inhibits cell growth) on human skin.

b\) A wide divergence of epidermal thickness among different locations on the body (Porter et al., 1998) and among human individuals (Waller and Maibach, 2005).

c\) Differences in the hygiene status among animal facilities.

d\) The influence of the development and growth cycles of hair on IFE of haired skin.

We believe that our observations can exclude the involvement of most of these extrinsic and intrinsic confounding factors by restricting our experiments to the paw IFE of congenic mice at one animal facility.

6\) The exact n number used for the quantifications should be included in the figure legends. In addition, the statistics seem inappropriate as it is not clear why a parametric test (Students-t) is used in cases where the data is unlikely to have equal variance and normal distribution (for example IF analyses of data from 3 mice). A more appropriate test such as the Mann-Whitney U test should be applied.

Please see the response to the Editor.

Reviewer \#2:

The authors examined the role of COL17 in regulating IFE homeostasis. How aging influences the homeostasis of the IFE and its stem cells has been elusive. This manuscript tackles this important issue. The data are in most parts beautiful. The study will provide novel insights into understanding epidermal changes during skin aging. There are additional experiments and discussions the authors can add to improve the manuscript.

1\) [Figure 1](#fig1){ref-type="fig"} showed epidermal hyperproliferation was observed in the neonates of Col17a1 -/- mice. The authors need to explain and clarify why the proliferative IFE phenotype of Col17a1 -/- mice gradually weaned. In addition, the authors need to examine the skin of different regions to confirm if epidermis was hypeproliferative in region-specific manner.

Please see the response to the Editor.

2\) The studies in [Figure 2](#fig2){ref-type="fig"} showing that COL17 regulates neonatal IFE proliferation through Wnt signaling are descriptive. The involvement of Wnt signaling in COL17-deficient proliferative IFE phenotype needs to be demonstrated in vitro and/or in vivo.

Please see the response to the Editor.

3\) Interestingly, the treatment of young mouse IFE samples with PKC inhibitor diminished apico-lateral membraneous COL17. To confirm if the changes of COL17 distribution were α-PKC-dependent, the authors need to confirm the level of phospho-PKC α in the IFE samples treated with Go6983 and myr PSI.

We utilized two inhibitors to exclude the non-specific drug activities on the treated cells at the effective in vivo and in vitro concentrations (Atwood et al., 2013; Wu et al., 2006). However, we regret that we have so far failed to clearly show decreased aPKC activity in skin treated with these inhibitors, but we strongly believe that the alteration of COL17 dynamics, as a membranous protein, in treated epidermis alone manifests as aberrant cell polarity. To further confirm our results, genetically modified mice with inducible aPKC inactivation might help. We have discussed this limitation in the revised manuscript.

4\) The authors stated the possible role of COL17 in the prevention of oncogenesis in the discussion but didn\'t provide any evidence for that. The authors need to study it in detail or tone down the statements.

Please see the response to the Editor.

Reviewer \#3:

\[...\]

The study is of a great interest since it suggest a novel function of collagen XVII as an anti-aging molecule of the skin. However, I have some comments addressing the methodological aspects and interpretation of results.

1\) Introduction, paragraph three: I would not call lamina lucida and lamina densa as components of basement membrane, since especially lamina lucida is generally considered as an artifact of tissue dehydration.

According to the reviewer's suggestion, we have deleted this sentence from the revised manuscript.

2\) Introduction: Please add a recent study which suggests that the expression of collagen XVII is decreased in aged human skin (Langton et al., 2016). Please also discuss this paper.

In accordance with the reviewer's suggestion, we have cited and discussed this paper in the revised manuscript.

3\) Results, first paragraph: For readers who are not familiar with cutaneous biology, the authors could clarify the relationship between the murine paw skin and human skin.

Please see the response to the Editor.

4\) Results, second paragraph: Why the expression of integrin β 2 and the three chains of laminin 332 were not measured?

We suspect that the reviewer meant integrin β 4 rather than β 2. We examined the relative expression of *Itgb4, Lamb3* and *Lamc2* in *Col17a1-/-* mice and control mice ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). There were no significant differences in expression between the groups.

5\) Results, subsection "COL17 regulates neonatal IFE proliferation through Wnt-β-catenin signaling ": The authors find that the immunostaining of LEF1, ββ-catenin and PH3 are changed in the skin biopsies of two JEB patients with COL17A1 null mutations in a similar way to newborn Col17a1-/- mice. However, in the Col17a1-/- mice these changes are transient, but not in human. What is the explanation for this finding? Was there hyperproliferation in JEB epidermis?

Please see the response to the Editor.

6\) Results, subsection "Distribution of COL17 is altered with physical aging": Is there hyperproliferation of epidermis in aging human skin?

According to a previous report (Waller et al., 2005), the proliferation rates and thickness of the epidermis depend on the body location in humans. We examined the expression of the proliferation markers in the planter skin of aged and young individuals by staining Ki-67 and PCNA. However, the number of marker-positive cells was highly variable even among a specific group. We suspect that the direction of sectioning relative to fingerprints greatly affected the results. In addition, human plantar skin is very large, and its thickness differs from the toe to the heel. As we can only utilize the available clinical samples, it is impossible to control the direction of sectioning in formalin-fixed paraffin-embedded samples and to ensure that the collected samples are derived from the exact anatomical area. Therefore, we are afraid that we cannot provide reliable data for this experiment.

7\) Results, Subsection "Atypical PKC controls the distribution of COL17 in IFE": Does the treatment of skin samples with EDTA really simulate aged IFE or rather the changes of calcium concentration in aged skin?

EDTA treatment simulates the changes of calcium concentration in the aged skin. We have accordingly corrected this in the manuscript.

8\) Discussion. The authors should discuss how their results are applied to human skin ie: What are the limitations of their study.

Please see the response to the Editor.

9\) Discussion, paragraph six. I found this chapter highly speculative and I would suggest to re-write it. It is known that collagen XVII is involved in squamous cell carcinoma and recent papers have suggested its importance in colon and lung cancer (Moilanen et al., Human Pathology; 2015, Liu et al., 2016 and 2016a). Moreover, I would not state that JEB patients with COL17A1 mutations have high frequency of multiple cutaneous SCC. In the paper by Yuen and Jonkman, only 2 out 14 JEB patients who developed SCC, were carriers of COL17A1 mutations. In addition, in the US National EB registry, the frequency of SCC in non-Herlitz JEB patients was very low (Fine et al., 2009).

Please see the response to the Editor.

\[Editors\' note: the author responses to the re-review follow.\]

The manuscript has improved as the link between col17 and Wnt has been better established (Wnt inhibitors, Top-gal), although especially the Top gal images don\'t look completely convincing regarding the selection of the area that is being measured. It would be better to have an unbiased approach for this.

As described in the original manuscript (Materials and method section), neonatal paw skin partially contains hair follicles and sweat glands, which are the major sources of Wnt activities. So, we definitely needed to exclude the effects from those appendages to adequately assess the relationship between IFE and Wnt signaling. Our observational area is confined to the regions that do not feature either hair follicles or sweat glands. We believe that this methodology is unbiased in terms of evaluating IFE in hindpaw skin.

To clarify our methodology, we have provided details on the localization of those appendages in paw skin ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). In this supplementary figure, we clearly indicated the area for the quantification for LacZ staining of ins-TOPGAL mice. We added the low and high magnification photos of these stainings in the figure ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

However, at the same time the manuscript has become somewhat confusing: on one hand luciferase assays demonstrate that the Wnt defect is maintained in cell culture, on the other hand the proliferation phenotype is not present. What is the explanation for this?

The TOPFLASH assay in our experiments did not indicate the defect of Wnt signaling in the absence of COL17. Instead, the assay showed that overexpression of human COL17 stabilizes and amplifies the Wnt signaling in vitro. These data confirm the intrinsic interaction between COL17 and Wnt signaling using HEK293 cells rather than addressing proliferation dynamics in IFE keratinocytes. These data may support the fact that Wnt ligands, known as hydrophobic, are stabilized with extracellular matrix (Rozario T and DeSimone DW, Dev Biol 2010; Willert K and Nusse R, Cold Spring Harb Perspect Biol 2012). We will discuss the discrepancy between in vitro cultured keratinocytes and in vivo *Col17a1-/-* paw IFE skin in point 4 below.

In addition, on one hand there are similarities in human and mouse skin but the keratinocytes show an opposite effect regarding proliferation.

The proliferation assays using normal human epidermal keratinocytes with COL17 knockdown showed a slight reduction in proliferation, and murine keratinocytes obtained from *Col17a1-/-* mice were reported to exhibit a similar reduction in proliferative ability (Tanimura et al., 2011). Based on these results, we believe that human and murine cultured keratinocytes with COL17 deficiency show similar characteristics in proliferation. We added this information to the revised manuscript and cited the reference mentioned above.

In addition to this fundamental issue, many of the discrepancies in the data are dismissed by discussion instead of attempting to tackle them experimentally.

If the epidermal structure (and not a minor barrier defect) is really the underlying factor, analysis of organotypic raft cultures should recapitulate the phenotype. Alternatively, the authors are welcome to consider other experimental approaches to address this.

We performed COL17 knock down experiments on reconstituted 3D epidermis using LabCyte EPI-KIT (J-TEC, Aichi, Japan) in accordance with the provider's protocol. In brief, we seeded human epidermal keratinocytes transfected with two COL17A1 siRNAs (Thermoscientific) or mock using Lipofectamine 3000 (Thermoscientific). The cells were cultured for 7days in cups in 24-well formats. The surface of the cells was exposed to the air interface for the cells to differentiate and reconstitute 3D epidermis. We treated these epidermis with 10µM BrdU (Σ) in the medium for 4hrs before the sampling. Utilizing qRT-PCR, we confirmed that COL17A1 gene expression was reduced in 3D epidermis treated with siRNAs ([Author response image 1A](#fig8){ref-type="fig"}). In contrast to the hyperproliferative phenotype of in vivo IFE paw skin in *Col17a1-/-* mice at P1, the 3D reconstituted epidermis treated with COL17A1 siRNA did not show a consistent proliferation tendency through PH3, BrdU and PCNA staining ([Author response image 1B-D](#fig8){ref-type="fig"}). Our observations on *Col17a1-/-* paw IFE showed that the phenotype starts from hyperproliferation in the neonatal stage but this tendency for proliferation is lost at 3 weeks-old. We believe that in vitro experiments on either 2D or 3D cultured cells may not reflect the chronological dynamics in in vivo epidermis (e.g., we cannot tell whether cultured cells in vitro correspond to 1 day-old or 20 day-old in vivo epidermis). Therefore, we do not include these data in the revised manuscript. We are aware that there are discrepancies between in vivo and in vitro data (2D or 3D) as the reviewers indicated. In other words, the hyperproliferative phenotype of *Col17a1-/-* paw IFE is simply dependent on in vivo conditions. We refined the text to describe these discrepancies in the revised manuscript.10.7554/eLife.26635.022Author response image 1.Proliferative ability of 3D reconstituted human epidermis treated with *COL17A1* siRNAs**DOI:** [http://dx.doi.org/10.7554/eLife.26635.022](10.7554/eLife.26635.022)

\(a\) Quantitative RT-PCR (qRT-PCR) of COL17A1 gene (n=8).

\(b\) The number of epidermal basal cells positively labeled for PH3 per mm epidermis (Mock; n=5, siRNAs; n=8, respectively).

(c-d) The number of epidermal basal cells positively labeled for BrdU (c) and PCNA (d) per mm epidermis (n=8). The data are presented as the means ± SE. \*0.01\<p\<0.05, \*\*\*\*p\<0.0001., One-way ANOVA followed by Tukey\'s test.

\</[Author response image 1](#fig8){ref-type="fig"} title/legend\>
